id	sid	tid	token	lemma	pos
dpc-2776	1	1	dermatology	dermatology	NOUN
dpc-2776	1	2	:	:	PUNCT
dpc-2776	1	3	practical	practical	ADJ
dpc-2776	1	4	and	and	CCONJ
dpc-2776	1	5	conceptual	conceptual	ADJ
dpc-2776	1	6	original	original	ADJ
dpc-2776	1	7	article	article	NOUN
dpc-2776	1	8	|	|	ADV
dpc-2776	1	9	dermatol	dermatol	ADJ
dpc-2776	1	10	pract	pract	NOUN
dpc-2776	1	11	concept	concept	NOUN
dpc-2776	1	12	.	.	PUNCT
dpc-2776	2	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	2	2	1	1	NUM
dpc-2776	2	3	skeletal	skeletal	ADJ
dpc-2776	2	4	side	side	NOUN
dpc-2776	2	5	effects	effect	NOUN
dpc-2776	2	6	of	of	ADP
dpc-2776	2	7	systemic	systemic	ADJ
dpc-2776	2	8	isotretinoin	isotretinoin	PROPN
dpc-2776	2	9	treatment	treatment	NOUN
dpc-2776	2	10	:	:	PUNCT
dpc-2776	2	11	do	do	AUX
dpc-2776	2	12	they	they	PRON
dpc-2776	2	13	depend	depend	VERB
dpc-2776	2	14	on	on	ADP
dpc-2776	2	15	age	age	NOUN
dpc-2776	2	16	,	,	PUNCT
dpc-2776	2	17	gender	gender	NOUN
dpc-2776	2	18	,	,	PUNCT
dpc-2776	2	19	treatment	treatment	NOUN
dpc-2776	2	20	duration	duration	NOUN
dpc-2776	2	21	,	,	PUNCT
dpc-2776	2	22	daily	daily	PROPN
dpc-2776	2	23	dose	dose	NOUN
dpc-2776	2	24	and	and	CCONJ
dpc-2776	2	25	isotretinoin	isotretinoin	NOUN
dpc-2776	2	26	-	-	PUNCT
dpc-2776	2	27	naiveness	naiveness	NOUN
dpc-2776	2	28	?	?	PUNCT
dpc-2776	3	1	defne	defne	NOUN
dpc-2776	3	2	özkoca1	özkoca1	NOUN
dpc-2776	3	3	,	,	PUNCT
dpc-2776	3	4	nazlı	nazlı	PROPN
dpc-2776	3	5	caf2	caf2	NOUN
dpc-2776	3	6	,	,	PUNCT
dpc-2776	3	7	nazan	nazan	NOUN
dpc-2776	3	8	nur	nur	VERB
dpc-2776	3	9	alacagöz	alacagöz	ADV
dpc-2776	3	10	yılmaz3	yılmaz3	PROPN
dpc-2776	3	11	,	,	PUNCT
dpc-2776	3	12	tuğba	tuğba	PROPN
dpc-2776	3	13	kevser	kevser	AUX
dpc-2776	4	1	uzunçakmak4	uzunçakmak4	PROPN
dpc-2776	4	2	,	,	PUNCT
dpc-2776	4	3	ayşenur	ayşenur	VERB
dpc-2776	4	4	özdil5	özdil5	PROPN
dpc-2776	4	5	,	,	PUNCT
dpc-2776	4	6	ayşe	ayşe	ADJ
dpc-2776	4	7	nilhan	nilhan	NOUN
dpc-2776	5	1	atsü6	atsü6	NOUN
dpc-2776	5	2	1	1	NUM
dpc-2776	5	3	zonguldak	zonguldak	PROPN
dpc-2776	5	4	atatürk	atatürk	NOUN
dpc-2776	5	5	state	state	PROPN
dpc-2776	5	6	hospital	hospital	NOUN
dpc-2776	5	7	,	,	PUNCT
dpc-2776	5	8	dermatology	dermatology	NOUN
dpc-2776	5	9	and	and	CCONJ
dpc-2776	5	10	venerology	venerology	NOUN
dpc-2776	5	11	clinic	clinic	PROPN
dpc-2776	5	12	,	,	PUNCT
dpc-2776	5	13	zonguldak	zonguldak	PROPN
dpc-2776	5	14	,	,	PUNCT
dpc-2776	5	15	turkey	turkey	NOUN
dpc-2776	5	16	2	2	NUM
dpc-2776	5	17	diyarbakır	diyarbakır	NOUN
dpc-2776	5	18	dağkapı	dağkapı	PROPN
dpc-2776	5	19	military	military	ADJ
dpc-2776	5	20	hospital	hospital	NOUN
dpc-2776	5	21	,	,	PUNCT
dpc-2776	5	22	dermatology	dermatology	NOUN
dpc-2776	5	23	and	and	CCONJ
dpc-2776	5	24	venerology	venerology	NOUN
dpc-2776	5	25	clinic	clinic	NOUN
dpc-2776	5	26	,	,	PUNCT
dpc-2776	5	27	diyarbakır	diyarbakır	PROPN
dpc-2776	5	28	,	,	PUNCT
dpc-2776	5	29	turkey	turkey	PROPN
dpc-2776	5	30	3	3	NUM
dpc-2776	5	31	zonguldak	zonguldak	PROPN
dpc-2776	5	32	atatürk	atatürk	NOUN
dpc-2776	5	33	state	state	PROPN
dpc-2776	5	34	hospital	hospital	NOUN
dpc-2776	5	35	,	,	PUNCT
dpc-2776	5	36	physical	physical	ADJ
dpc-2776	5	37	therapy	therapy	NOUN
dpc-2776	5	38	and	and	CCONJ
dpc-2776	5	39	rehabilitation	rehabilitation	NOUN
dpc-2776	5	40	clinic	clinic	NOUN
dpc-2776	5	41	,	,	PUNCT
dpc-2776	5	42	zonguldak	zonguldak	PROPN
dpc-2776	5	43	,	,	PUNCT
dpc-2776	5	44	turkey	turkey	NOUN
dpc-2776	5	45	4	4	NUM
dpc-2776	5	46	şişli	şişli	NOUN
dpc-2776	5	47	memorial	memorial	ADJ
dpc-2776	5	48	hospital	hospital	NOUN
dpc-2776	5	49	,	,	PUNCT
dpc-2776	5	50	dermatology	dermatology	NOUN
dpc-2776	5	51	and	and	CCONJ
dpc-2776	5	52	venerology	venerology	NOUN
dpc-2776	5	53	clinic	clinic	NOUN
dpc-2776	5	54	,	,	PUNCT
dpc-2776	5	55	i̇stanbul	i̇stanbul	ADV
dpc-2776	5	56	,	,	PUNCT
dpc-2776	5	57	turkey	turkey	NOUN
dpc-2776	5	58	5	5	NUM
dpc-2776	5	59	i̇stanbul	i̇stanbul	NOUN
dpc-2776	5	60	university	university	NOUN
dpc-2776	5	61	-	-	PUNCT
dpc-2776	5	62	cerrahpaşa	cerrahpaşa	PROPN
dpc-2776	5	63	,	,	PUNCT
dpc-2776	5	64	cerrahpaşa	cerrahpaşa	VERB
dpc-2776	5	65	medical	medical	ADJ
dpc-2776	5	66	faculty	faculty	PROPN
dpc-2776	5	67	,	,	PUNCT
dpc-2776	5	68	department	department	NOUN
dpc-2776	5	69	of	of	ADP
dpc-2776	5	70	public	public	ADJ
dpc-2776	5	71	health	health	NOUN
dpc-2776	5	72	,	,	PUNCT
dpc-2776	5	73	i̇stanbul	i̇stanbul	ADV
dpc-2776	5	74	,	,	PUNCT
dpc-2776	5	75	turkey	turkey	PROPN
dpc-2776	5	76	6	6	NUM
dpc-2776	5	77	i̇stanbul	i̇stanbul	NOUN
dpc-2776	5	78	kent	kent	PROPN
dpc-2776	5	79	university	university	PROPN
dpc-2776	5	80	,	,	PUNCT
dpc-2776	5	81	department	department	NOUN
dpc-2776	5	82	of	of	ADP
dpc-2776	5	83	dermatology	dermatology	NOUN
dpc-2776	5	84	and	and	CCONJ
dpc-2776	5	85	venerology	venerology	NOUN
dpc-2776	5	86	,	,	PUNCT
dpc-2776	5	87	i̇stanbul	i̇stanbul	ADV
dpc-2776	5	88	,	,	PUNCT
dpc-2776	5	89	turkey	turkey	PROPN
dpc-2776	5	90	key	key	ADJ
dpc-2776	5	91	words	word	NOUN
dpc-2776	5	92	:	:	PUNCT
dpc-2776	5	93	acne	acne	NOUN
dpc-2776	5	94	vulgaris	vulgaris	NOUN
dpc-2776	5	95	,	,	PUNCT
dpc-2776	5	96	fatigue	fatigue	NOUN
dpc-2776	5	97	,	,	PUNCT
dpc-2776	5	98	low	low	ADJ
dpc-2776	5	99	back	back	ADJ
dpc-2776	5	100	pain	pain	NOUN
dpc-2776	5	101	,	,	PUNCT
dpc-2776	5	102	isotretinoin	isotretinoin	PROPN
dpc-2776	5	103	,	,	PUNCT
dpc-2776	5	104	myalgia	myalgia	PROPN
dpc-2776	5	105	citation	citation	NOUN
dpc-2776	5	106	:	:	PUNCT
dpc-2776	6	1	özkoca	özkoca	PROPN
dpc-2776	6	2	d	d	PROPN
dpc-2776	6	3	,	,	PUNCT
dpc-2776	6	4	caf	caf	NOUN
dpc-2776	6	5	n	n	CCONJ
dpc-2776	6	6	,	,	PUNCT
dpc-2776	6	7	alacagöz	alacagöz	VERB
dpc-2776	6	8	yılmaz	yılmaz	PROPN
dpc-2776	6	9	nn	nn	PROPN
dpc-2776	6	10	,	,	PUNCT
dpc-2776	6	11	uzunçakmak	uzunçakmak	PROPN
dpc-2776	6	12	tk	tk	PROPN
dpc-2776	6	13	,	,	PUNCT
dpc-2776	6	14	özdil	özdil	ADV
dpc-2776	6	15	a	a	PRON
dpc-2776	6	16	,	,	PUNCT
dpc-2776	6	17	atsü	atsü	PROPN
dpc-2776	6	18	an	an	X
dpc-2776	6	19	.	.	PUNCT
dpc-2776	6	20	skeletal	skeletal	ADJ
dpc-2776	6	21	side	side	NOUN
dpc-2776	6	22	effects	effect	NOUN
dpc-2776	6	23	of	of	ADP
dpc-2776	6	24	systemic	systemic	ADJ
dpc-2776	6	25	isotretinoin	isotretinoin	PROPN
dpc-2776	6	26	treatment	treatment	NOUN
dpc-2776	6	27	:	:	PUNCT
dpc-2776	6	28	do	do	AUX
dpc-2776	6	29	they	they	PRON
dpc-2776	6	30	depend	depend	VERB
dpc-2776	6	31	on	on	ADP
dpc-2776	6	32	age	age	NOUN
dpc-2776	6	33	,	,	PUNCT
dpc-2776	6	34	gender	gender	NOUN
dpc-2776	6	35	,	,	PUNCT
dpc-2776	6	36	treatment	treatment	NOUN
dpc-2776	6	37	duration	duration	NOUN
dpc-2776	6	38	,	,	PUNCT
dpc-2776	6	39	daily	daily	PROPN
dpc-2776	6	40	dose	dose	NOUN
dpc-2776	6	41	and	and	CCONJ
dpc-2776	6	42	isotretinoin	isotretinoin	NOUN
dpc-2776	6	43	-	-	PUNCT
dpc-2776	6	44	naiveness	naiveness	NOUN
dpc-2776	6	45	?	?	PUNCT
dpc-2776	7	1	dermatol	dermatol	NOUN
dpc-2776	7	2	pract	pract	PROPN
dpc-2776	7	3	concept	concept	NOUN
dpc-2776	7	4	.	.	PUNCT
dpc-2776	8	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	8	2	.	.	X
dpc-2776	8	3	doi	doi	NOUN
dpc-2776	8	4	:	:	PUNCT
dpc-2776	8	5	https://doi.org/10.5826/dpc.1302a121	https://doi.org/10.5826/dpc.1302a121	PROPN
dpc-2776	8	6	accepted	accept	VERB
dpc-2776	8	7	:	:	PUNCT
dpc-2776	8	8	november	november	PROPN
dpc-2776	8	9	14	14	NUM
dpc-2776	8	10	,	,	PUNCT
dpc-2776	8	11	2022	2022	NUM
dpc-2776	8	12	;	;	PUNCT
dpc-2776	8	13	published	publish	VERB
dpc-2776	8	14	:	:	PUNCT
dpc-2776	9	1	april	april	PROPN
dpc-2776	9	2	2023	2023	NUM
dpc-2776	9	3	copyright	copyright	NOUN
dpc-2776	9	4	:	:	PUNCT
dpc-2776	9	5	©	©	PROPN
dpc-2776	9	6	2023	2023	NUM
dpc-2776	9	7	özkoca	özkoca	NOUN
dpc-2776	9	8	et	et	PROPN
dpc-2776	9	9	al	al	PROPN
dpc-2776	9	10	.	.	PUNCT
dpc-2776	10	1	this	this	PRON
dpc-2776	10	2	is	be	AUX
dpc-2776	10	3	an	an	DET
dpc-2776	10	4	open	open	ADJ
dpc-2776	10	5	-	-	PUNCT
dpc-2776	10	6	access	access	NOUN
dpc-2776	10	7	article	article	NOUN
dpc-2776	10	8	distributed	distribute	VERB
dpc-2776	10	9	under	under	ADP
dpc-2776	10	10	the	the	DET
dpc-2776	10	11	terms	term	NOUN
dpc-2776	10	12	of	of	ADP
dpc-2776	10	13	the	the	DET
dpc-2776	10	14	creative	creative	ADJ
dpc-2776	10	15	commons	common	NOUN
dpc-2776	10	16	attribution	attribution	NOUN
dpc-2776	10	17	-	-	PUNCT
dpc-2776	10	18	noncommercial	noncommercial	ADJ
dpc-2776	10	19	license	license	NOUN
dpc-2776	10	20	(	(	PUNCT
dpc-2776	10	21	by	by	ADP
dpc-2776	10	22	-	-	PUNCT
dpc-2776	10	23	nc-4.0	nc-4.0	NOUN
dpc-2776	10	24	)	)	PUNCT
dpc-2776	10	25	,	,	PUNCT
dpc-2776	10	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2776	10	27	,	,	PUNCT
dpc-2776	10	28	which	which	PRON
dpc-2776	10	29	permits	permit	VERB
dpc-2776	10	30	unrestricted	unrestricted	ADJ
dpc-2776	10	31	noncommercial	noncommercial	ADJ
dpc-2776	10	32	use	use	NOUN
dpc-2776	10	33	,	,	PUNCT
dpc-2776	10	34	distribution	distribution	NOUN
dpc-2776	10	35	,	,	PUNCT
dpc-2776	10	36	and	and	CCONJ
dpc-2776	10	37	reproduction	reproduction	NOUN
dpc-2776	10	38	in	in	ADP
dpc-2776	10	39	any	any	DET
dpc-2776	10	40	medium	medium	NOUN
dpc-2776	10	41	,	,	PUNCT
dpc-2776	10	42	provided	provide	VERB
dpc-2776	10	43	the	the	DET
dpc-2776	10	44	original	original	ADJ
dpc-2776	10	45	authors	author	NOUN
dpc-2776	10	46	and	and	CCONJ
dpc-2776	10	47	source	source	NOUN
dpc-2776	10	48	are	be	AUX
dpc-2776	10	49	credited	credit	VERB
dpc-2776	10	50	.	.	PUNCT
dpc-2776	11	1	funding	funding	NOUN
dpc-2776	11	2	:	:	PUNCT
dpc-2776	11	3	none	none	NOUN
dpc-2776	11	4	.	.	PUNCT
dpc-2776	12	1	competing	compete	VERB
dpc-2776	12	2	interests	interest	NOUN
dpc-2776	12	3	:	:	PUNCT
dpc-2776	12	4	none	none	NOUN
dpc-2776	12	5	.	.	PUNCT
dpc-2776	13	1	authorship	authorship	NOUN
dpc-2776	13	2	:	:	PUNCT
dpc-2776	13	3	all	all	DET
dpc-2776	13	4	authors	author	NOUN
dpc-2776	13	5	have	have	AUX
dpc-2776	13	6	contributed	contribute	VERB
dpc-2776	13	7	significantly	significantly	ADV
dpc-2776	13	8	to	to	ADP
dpc-2776	13	9	this	this	DET
dpc-2776	13	10	publication	publication	NOUN
dpc-2776	13	11	.	.	PUNCT
dpc-2776	14	1	corresponding	correspond	VERB
dpc-2776	14	2	author	author	NOUN
dpc-2776	14	3	:	:	PUNCT
dpc-2776	14	4	defne	defne	NOUN
dpc-2776	14	5	özkoca	özkoca	NOUN
dpc-2776	14	6	,	,	PUNCT
dpc-2776	14	7	md	md	PROPN
dpc-2776	14	8	,	,	PUNCT
dpc-2776	14	9	zonguldak	zonguldak	PROPN
dpc-2776	14	10	atatürk	atatürk	PROPN
dpc-2776	14	11	devlet	devlet	PROPN
dpc-2776	14	12	hastanesi	hastanesi	PROPN
dpc-2776	14	13	,	,	PUNCT
dpc-2776	14	14	site	site	NOUN
dpc-2776	14	15	ek	ek	PROPN
dpc-2776	14	16	binası	binası	PROPN
dpc-2776	14	17	,	,	PUNCT
dpc-2776	14	18	bahçelievler	bahçelievler	NOUN
dpc-2776	14	19	,	,	PUNCT
dpc-2776	14	20	zonguldak	zonguldak	PROPN
dpc-2776	14	21	,	,	PUNCT
dpc-2776	14	22	turkey	turkey	PROPN
dpc-2776	14	23	.	.	PUNCT
dpc-2776	15	1	phone	phone	NOUN
dpc-2776	15	2	:	:	PUNCT
dpc-2776	15	3	00905366561000	00905366561000	NUM
dpc-2776	15	4	e	e	X
dpc-2776	15	5	-	-	NOUN
dpc-2776	15	6	mail	mail	NOUN
dpc-2776	15	7	:	:	PUNCT
dpc-2776	16	1	defneozkoca@yahoo.com	defneozkoca@yahoo.com	NUM
dpc-2776	16	2	introduction	introduction	NOUN
dpc-2776	16	3	:	:	PUNCT
dpc-2776	16	4	systemic	systemic	ADJ
dpc-2776	16	5	isotretinoin	isotretinoin	PROPN
dpc-2776	16	6	is	be	AUX
dpc-2776	16	7	the	the	DET
dpc-2776	16	8	most	most	ADV
dpc-2776	16	9	effective	effective	ADJ
dpc-2776	16	10	treatment	treatment	NOUN
dpc-2776	16	11	modality	modality	NOUN
dpc-2776	16	12	in	in	ADP
dpc-2776	16	13	acne	acne	NOUN
dpc-2776	16	14	vulgaris	vulgaris	NOUN
dpc-2776	16	15	;	;	PUNCT
dpc-2776	16	16	however	however	ADV
dpc-2776	16	17	,	,	PUNCT
dpc-2776	16	18	both	both	DET
dpc-2776	16	19	patients	patient	NOUN
dpc-2776	16	20	and	and	CCONJ
dpc-2776	16	21	physicians	physician	NOUN
dpc-2776	16	22	hesitate	hesitate	VERB
dpc-2776	16	23	to	to	PART
dpc-2776	16	24	use	use	VERB
dpc-2776	16	25	it	it	PRON
dpc-2776	16	26	due	due	ADJ
dpc-2776	16	27	its	its	PRON
dpc-2776	16	28	side	side	NOUN
dpc-2776	16	29	effects	effect	NOUN
dpc-2776	16	30	.	.	PUNCT
dpc-2776	17	1	objectives	objective	NOUN
dpc-2776	17	2	:	:	PUNCT
dpc-2776	17	3	the	the	DET
dpc-2776	17	4	aim	aim	NOUN
dpc-2776	17	5	of	of	ADP
dpc-2776	17	6	this	this	DET
dpc-2776	17	7	study	study	NOUN
dpc-2776	17	8	is	be	AUX
dpc-2776	17	9	to	to	PART
dpc-2776	17	10	determine	determine	VERB
dpc-2776	17	11	the	the	DET
dpc-2776	17	12	prevalence	prevalence	NOUN
dpc-2776	17	13	of	of	ADP
dpc-2776	17	14	fatigue	fatigue	NOUN
dpc-2776	17	15	,	,	PUNCT
dpc-2776	17	16	myalgia	myalgia	NOUN
dpc-2776	17	17	and	and	CCONJ
dpc-2776	17	18	low	low	ADJ
dpc-2776	17	19	back	back	ADJ
dpc-2776	17	20	pain	pain	NOUN
dpc-2776	17	21	during	during	ADP
dpc-2776	17	22	systemic	systemic	ADJ
dpc-2776	17	23	isotretinoin	isotretinoin	PROPN
dpc-2776	17	24	treatment	treatment	NOUN
dpc-2776	17	25	;	;	PUNCT
dpc-2776	17	26	and	and	CCONJ
dpc-2776	17	27	to	to	PART
dpc-2776	17	28	determine	determine	VERB
dpc-2776	17	29	their	their	PRON
dpc-2776	17	30	relationship	relationship	NOUN
dpc-2776	17	31	with	with	ADP
dpc-2776	17	32	age	age	NOUN
dpc-2776	17	33	,	,	PUNCT
dpc-2776	17	34	gender	gender	NOUN
dpc-2776	17	35	,	,	PUNCT
dpc-2776	17	36	treatment	treatment	NOUN
dpc-2776	17	37	duration	duration	NOUN
dpc-2776	17	38	,	,	PUNCT
dpc-2776	17	39	daily	daily	PROPN
dpc-2776	17	40	isotretinoin	isotretinoin	PROPN
dpc-2776	17	41	dose	dose	PROPN
dpc-2776	17	42	and	and	CCONJ
dpc-2776	17	43	isotretinoin	isotretinoin	PROPN
dpc-2776	17	44	-	-	PUNCT
dpc-2776	17	45	naiveness	naiveness	NOUN
dpc-2776	17	46	of	of	ADP
dpc-2776	17	47	the	the	DET
dpc-2776	17	48	patient	patient	NOUN
dpc-2776	17	49	.	.	PUNCT
dpc-2776	18	1	methods	method	NOUN
dpc-2776	18	2	:	:	PUNCT
dpc-2776	18	3	this	this	PRON
dpc-2776	18	4	is	be	AUX
dpc-2776	18	5	a	a	DET
dpc-2776	18	6	cross	cross	ADJ
dpc-2776	18	7	sectional	sectional	ADJ
dpc-2776	18	8	study	study	NOUN
dpc-2776	18	9	including	include	VERB
dpc-2776	18	10	the	the	DET
dpc-2776	18	11	acne	acne	NOUN
dpc-2776	18	12	vulgaris	vulgaris	NOUN
dpc-2776	18	13	patients	patient	NOUN
dpc-2776	18	14	,	,	PUNCT
dpc-2776	18	15	aged	age	VERB
dpc-2776	18	16	between	between	ADP
dpc-2776	18	17	13	13	NUM
dpc-2776	18	18	to	to	PART
dpc-2776	18	19	40	40	NUM
dpc-2776	18	20	 	 	SPACE
dpc-2776	18	21	years	year	NOUN
dpc-2776	18	22	,	,	PUNCT
dpc-2776	18	23	who	who	PRON
dpc-2776	18	24	have	have	AUX
dpc-2776	18	25	at	at	ADV
dpc-2776	18	26	least	least	ADJ
dpc-2776	18	27	received	receive	VERB
dpc-2776	18	28	one	one	NUM
dpc-2776	18	29	month	month	NOUN
dpc-2776	18	30	of	of	ADP
dpc-2776	18	31	oral	oral	ADJ
dpc-2776	18	32	isotretinoin	isotretinoin	PROPN
dpc-2776	18	33	treatment	treatment	NOUN
dpc-2776	18	34	.	.	PUNCT
dpc-2776	19	1	patients	patient	NOUN
dpc-2776	19	2	were	be	AUX
dpc-2776	19	3	questioned	question	VERB
dpc-2776	19	4	for	for	ADP
dpc-2776	19	5	side	side	NOUN
dpc-2776	19	6	effects	effect	NOUN
dpc-2776	19	7	during	during	ADP
dpc-2776	19	8	their	their	PRON
dpc-2776	19	9	follow	follow	VERB
dpc-2776	19	10	-	-	PUNCT
dpc-2776	19	11	up	up	ADP
dpc-2776	19	12	visits	visit	NOUN
dpc-2776	19	13	;	;	PUNCT
dpc-2776	19	14	a	a	DET
dpc-2776	19	15	physical	physical	ADJ
dpc-2776	19	16	therapy	therapy	NOUN
dpc-2776	19	17	and	and	CCONJ
dpc-2776	19	18	rehabilitation	rehabilitation	NOUN
dpc-2776	19	19	specialist	specialist	NOUN
dpc-2776	19	20	further	far	ADV
dpc-2776	19	21	evaluated	evaluate	VERB
dpc-2776	19	22	patients	patient	NOUN
dpc-2776	19	23	complaining	complain	VERB
dpc-2776	19	24	of	of	ADP
dpc-2776	19	25	low	low	ADJ
dpc-2776	19	26	back	back	ADJ
dpc-2776	19	27	pain	pain	NOUN
dpc-2776	19	28	.	.	PUNCT
dpc-2776	20	1	results	result	NOUN
dpc-2776	20	2	:	:	PUNCT
dpc-2776	20	3	fatigue	fatigue	NOUN
dpc-2776	20	4	was	be	AUX
dpc-2776	20	5	reported	report	VERB
dpc-2776	20	6	by	by	ADP
dpc-2776	20	7	4.4	4.4	NUM
dpc-2776	20	8	%	%	NOUN
dpc-2776	20	9	of	of	ADP
dpc-2776	20	10	the	the	DET
dpc-2776	20	11	patients	patient	NOUN
dpc-2776	20	12	,	,	PUNCT
dpc-2776	20	13	myalgia	myalgia	NOUN
dpc-2776	20	14	by	by	ADP
dpc-2776	20	15	2.8	2.8	NUM
dpc-2776	20	16	%	%	NOUN
dpc-2776	20	17	and	and	CCONJ
dpc-2776	20	18	low	low	ADJ
dpc-2776	20	19	back	back	ADJ
dpc-2776	20	20	pain	pain	NOUN
dpc-2776	20	21	by	by	ADP
dpc-2776	20	22	25	25	NUM
dpc-2776	20	23	%	%	NOUN
dpc-2776	20	24	of	of	ADP
dpc-2776	20	25	the	the	DET
dpc-2776	20	26	patients	patient	NOUN
dpc-2776	20	27	;	;	PUNCT
dpc-2776	20	28	2.2	2.2	NUM
dpc-2776	20	29	%	%	NOUN
dpc-2776	20	30	had	have	VERB
dpc-2776	20	31	inflammatory	inflammatory	ADJ
dpc-2776	20	32	and	and	CCONJ
dpc-2776	20	33	22.8	22.8	NUM
dpc-2776	20	34	%	%	NOUN
dpc-2776	20	35	had	have	VERB
dpc-2776	20	36	mechanical	mechanical	ADJ
dpc-2776	20	37	low	low	ADJ
dpc-2776	20	38	back	back	ADJ
dpc-2776	20	39	pain	pain	NOUN
dpc-2776	20	40	.	.	PUNCT
dpc-2776	21	1	none	none	NOUN
dpc-2776	21	2	of	of	ADP
dpc-2776	21	3	the	the	DET
dpc-2776	21	4	patients	patient	NOUN
dpc-2776	21	5	abstract	abstract	VERB
dpc-2776	21	6	2	2	NUM
dpc-2776	21	7	original	original	ADJ
dpc-2776	21	8	article	article	NOUN
dpc-2776	21	9	|	|	ADV
dpc-2776	21	10	dermatol	dermatol	ADJ
dpc-2776	21	11	pract	pract	NOUN
dpc-2776	21	12	concept	concept	NOUN
dpc-2776	21	13	.	.	PUNCT
dpc-2776	22	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	22	2	introduction	introduction	NOUN
dpc-2776	22	3	systemic	systemic	ADJ
dpc-2776	22	4	isotretinoin	isotretinoin	PROPN
dpc-2776	22	5	(	(	PUNCT
dpc-2776	22	6	13	13	NUM
dpc-2776	22	7	-	-	PUNCT
dpc-2776	22	8	cis	cis	NOUN
dpc-2776	22	9	retinoic	retinoic	NOUN
dpc-2776	22	10	acid	acid	NOUN
dpc-2776	22	11	)	)	PUNCT
dpc-2776	22	12	is	be	AUX
dpc-2776	22	13	the	the	DET
dpc-2776	22	14	most	most	ADV
dpc-2776	22	15	effective	effective	ADJ
dpc-2776	22	16	treatment	treatment	NOUN
dpc-2776	22	17	modality	modality	NOUN
dpc-2776	22	18	for	for	ADP
dpc-2776	22	19	acne	acne	NOUN
dpc-2776	22	20	vulgaris	vulgaris	NOUN
dpc-2776	22	21	given	give	VERB
dpc-2776	22	22	that	that	SCONJ
dpc-2776	22	23	it	it	PRON
dpc-2776	22	24	is	be	AUX
dpc-2776	22	25	the	the	DET
dpc-2776	22	26	only	only	ADJ
dpc-2776	22	27	treatment	treatment	NOUN
dpc-2776	22	28	method	method	NOUN
dpc-2776	22	29	that	that	PRON
dpc-2776	22	30	targets	target	VERB
dpc-2776	22	31	all	all	DET
dpc-2776	22	32	four	four	NUM
dpc-2776	22	33	of	of	ADP
dpc-2776	22	34	the	the	DET
dpc-2776	22	35	major	major	ADJ
dpc-2776	22	36	etiological	etiological	ADJ
dpc-2776	22	37	factors	factor	NOUN
dpc-2776	22	38	of	of	ADP
dpc-2776	22	39	acne	acne	NOUN
dpc-2776	22	40	vulgaris	vulgaris	NOUN
dpc-2776	22	41	.	.	PUNCT
dpc-2776	23	1	the	the	DET
dpc-2776	23	2	us	us	PROPN
dpc-2776	23	3	food	food	NOUN
dpc-2776	23	4	and	and	CCONJ
dpc-2776	23	5	drug	drug	PROPN
dpc-2776	23	6	administration	administration	NOUN
dpc-2776	23	7	have	have	AUX
dpc-2776	23	8	approved	approve	VERB
dpc-2776	23	9	its	its	PRON
dpc-2776	23	10	use	use	NOUN
dpc-2776	23	11	for	for	ADP
dpc-2776	23	12	the	the	DET
dpc-2776	23	13	treatment	treatment	NOUN
dpc-2776	23	14	of	of	ADP
dpc-2776	23	15	severe	severe	ADJ
dpc-2776	23	16	acne	acne	NOUN
dpc-2776	23	17	vulgaris	vulgaris	NOUN
dpc-2776	23	18	in	in	ADP
dpc-2776	23	19	1982	1982	NUM
dpc-2776	23	20	[	[	X
dpc-2776	23	21	1	1	NUM
dpc-2776	23	22	]	]	PUNCT
dpc-2776	23	23	.	.	PUNCT
dpc-2776	24	1	the	the	DET
dpc-2776	24	2	common	common	ADJ
dpc-2776	24	3	side	side	NOUN
dpc-2776	24	4	effects	effect	NOUN
dpc-2776	24	5	of	of	ADP
dpc-2776	24	6	systemic	systemic	ADJ
dpc-2776	24	7	isotretinoin	isotretinoin	PROPN
dpc-2776	24	8	treatment	treatment	NOUN
dpc-2776	24	9	are	be	AUX
dpc-2776	24	10	cheilitis	cheilitis	NOUN
dpc-2776	24	11	,	,	PUNCT
dpc-2776	24	12	xerosis	xerosis	NOUN
dpc-2776	24	13	,	,	PUNCT
dpc-2776	24	14	xerophthalmia	xerophthalmia	NOUN
dpc-2776	24	15	,	,	PUNCT
dpc-2776	24	16	and	and	CCONJ
dpc-2776	24	17	myalgias	myalgias	PROPN
dpc-2776	24	18	.	.	PUNCT
dpc-2776	25	1	its	its	PRON
dpc-2776	25	2	tendency	tendency	NOUN
dpc-2776	25	3	for	for	ADP
dpc-2776	25	4	causing	cause	VERB
dpc-2776	25	5	depression	depression	NOUN
dpc-2776	25	6	,	,	PUNCT
dpc-2776	25	7	and	and	CCONJ
dpc-2776	25	8	suicidal	suicidal	ADJ
dpc-2776	25	9	ideation	ideation	NOUN
dpc-2776	25	10	still	still	ADV
dpc-2776	25	11	remains	remain	VERB
dpc-2776	25	12	controversial	controversial	ADJ
dpc-2776	25	13	[	[	X
dpc-2776	25	14	2	2	NUM
dpc-2776	25	15	]	]	PUNCT
dpc-2776	25	16	.	.	PUNCT
dpc-2776	26	1	arthralgia	arthralgia	PROPN
dpc-2776	26	2	may	may	AUX
dpc-2776	26	3	also	also	ADV
dpc-2776	26	4	be	be	AUX
dpc-2776	26	5	experienced	experience	VERB
dpc-2776	26	6	by	by	ADP
dpc-2776	26	7	the	the	DET
dpc-2776	26	8	patients	patient	NOUN
dpc-2776	26	9	during	during	ADP
dpc-2776	26	10	systemic	systemic	ADJ
dpc-2776	26	11	isotretinoin	isotretinoin	PROPN
dpc-2776	26	12	therapy	therapy	NOUN
dpc-2776	26	13	;	;	PUNCT
dpc-2776	26	14	20	20	NUM
dpc-2776	26	15	%	%	NOUN
dpc-2776	26	16	of	of	ADP
dpc-2776	26	17	the	the	DET
dpc-2776	26	18	patients	patient	NOUN
dpc-2776	26	19	complain	complain	VERB
dpc-2776	26	20	of	of	ADP
dpc-2776	26	21	either	either	CCONJ
dpc-2776	26	22	myalgia	myalgia	NOUN
dpc-2776	26	23	or	or	CCONJ
dpc-2776	26	24	arthralgia	arthralgia	NOUN
dpc-2776	26	25	[	[	X
dpc-2776	26	26	3	3	NUM
dpc-2776	26	27	]	]	PUNCT
dpc-2776	26	28	.	.	PUNCT
dpc-2776	27	1	inflammatory	inflammatory	ADJ
dpc-2776	27	2	low	low	ADJ
dpc-2776	27	3	back	back	ADJ
dpc-2776	27	4	pain	pain	NOUN
dpc-2776	27	5	is	be	AUX
dpc-2776	27	6	a	a	DET
dpc-2776	27	7	very	very	ADV
dpc-2776	27	8	common	common	ADJ
dpc-2776	27	9	side	side	NOUN
dpc-2776	27	10	effect	effect	NOUN
dpc-2776	27	11	of	of	ADP
dpc-2776	27	12	systemic	systemic	ADJ
dpc-2776	27	13	isotretinoin	isotretinoin	PROPN
dpc-2776	27	14	therapy	therapy	NOUN
dpc-2776	27	15	;	;	PUNCT
dpc-2776	27	16	sacroiliitis	sacroiliitis	NOUN
dpc-2776	27	17	and	and	CCONJ
dpc-2776	27	18	tendinitis	tendinitis	PROPN
dpc-2776	27	19	may	may	AUX
dpc-2776	27	20	also	also	ADV
dpc-2776	27	21	occur	occur	VERB
dpc-2776	27	22	although	although	SCONJ
dpc-2776	27	23	much	much	ADV
dpc-2776	27	24	rare	rare	ADJ
dpc-2776	27	25	.	.	PUNCT
dpc-2776	28	1	the	the	DET
dpc-2776	28	2	low	low	ADJ
dpc-2776	28	3	back	back	NOUN
dpc-2776	28	4	pain	pain	NOUN
dpc-2776	28	5	ceases	cease	VERB
dpc-2776	28	6	with	with	ADP
dpc-2776	28	7	dose	dose	NOUN
dpc-2776	28	8	reduction	reduction	NOUN
dpc-2776	28	9	[	[	X
dpc-2776	28	10	4,5	4,5	NUM
dpc-2776	28	11	]	]	PUNCT
dpc-2776	28	12	.	.	PUNCT
dpc-2776	29	1	objectives	objective	VERB
dpc-2776	29	2	the	the	DET
dpc-2776	29	3	aim	aim	NOUN
dpc-2776	29	4	of	of	ADP
dpc-2776	29	5	this	this	DET
dpc-2776	29	6	study	study	NOUN
dpc-2776	29	7	is	be	AUX
dpc-2776	29	8	to	to	PART
dpc-2776	29	9	determine	determine	VERB
dpc-2776	29	10	the	the	DET
dpc-2776	29	11	incidence	incidence	NOUN
dpc-2776	29	12	of	of	ADP
dpc-2776	29	13	fatigue	fatigue	NOUN
dpc-2776	29	14	,	,	PUNCT
dpc-2776	29	15	myalgia	myalgia	NOUN
dpc-2776	29	16	and	and	CCONJ
dpc-2776	29	17	low	low	ADJ
dpc-2776	29	18	back	back	ADJ
dpc-2776	29	19	pain	pain	NOUN
dpc-2776	29	20	(	(	PUNCT
dpc-2776	29	21	inflammatory	inflammatory	ADJ
dpc-2776	29	22	or	or	CCONJ
dpc-2776	29	23	mechanical	mechanical	ADJ
dpc-2776	29	24	)	)	PUNCT
dpc-2776	29	25	in	in	ADP
dpc-2776	29	26	acne	acne	NOUN
dpc-2776	29	27	vulgaris	vulgaris	NOUN
dpc-2776	29	28	patients	patient	NOUN
dpc-2776	29	29	receiving	receive	VERB
dpc-2776	29	30	oral	oral	ADJ
dpc-2776	29	31	isotretinoin	isotretinoin	PROPN
dpc-2776	29	32	therapy	therapy	NOUN
dpc-2776	29	33	;	;	PUNCT
dpc-2776	29	34	and	and	CCONJ
dpc-2776	29	35	to	to	PART
dpc-2776	29	36	determine	determine	VERB
dpc-2776	29	37	the	the	DET
dpc-2776	29	38	relationship	relationship	NOUN
dpc-2776	29	39	of	of	ADP
dpc-2776	29	40	these	these	DET
dpc-2776	29	41	side	side	NOUN
dpc-2776	29	42	-	-	PUNCT
dpc-2776	29	43	effects	effect	NOUN
dpc-2776	29	44	to	to	ADP
dpc-2776	29	45	the	the	DET
dpc-2776	29	46	age	age	NOUN
dpc-2776	29	47	and	and	CCONJ
dpc-2776	29	48	the	the	DET
dpc-2776	29	49	gender	gender	NOUN
dpc-2776	29	50	of	of	ADP
dpc-2776	29	51	the	the	DET
dpc-2776	29	52	patient	patient	NOUN
dpc-2776	29	53	,	,	PUNCT
dpc-2776	29	54	the	the	DET
dpc-2776	29	55	isotretinoin	isotretinoin	PROPN
dpc-2776	29	56	dosing	dose	VERB
dpc-2776	29	57	regimen	regiman	NOUN
dpc-2776	29	58	,	,	PUNCT
dpc-2776	29	59	the	the	DET
dpc-2776	29	60	duration	duration	NOUN
dpc-2776	29	61	of	of	ADP
dpc-2776	29	62	isotretinoin	isotretinoin	PROPN
dpc-2776	29	63	therapy	therapy	NOUN
dpc-2776	29	64	and	and	CCONJ
dpc-2776	29	65	the	the	DET
dpc-2776	29	66	isotretinoin	isotretinoin	NOUN
dpc-2776	29	67	-	-	PUNCT
dpc-2776	29	68	naiveness	naiveness	NOUN
dpc-2776	29	69	of	of	ADP
dpc-2776	29	70	the	the	DET
dpc-2776	29	71	patient	patient	NOUN
dpc-2776	29	72	.	.	PUNCT
dpc-2776	30	1	methods	method	NOUN
dpc-2776	30	2	patient	patient	ADJ
dpc-2776	30	3	selection	selection	NOUN
dpc-2776	30	4	acne	acne	NOUN
dpc-2776	30	5	vulgaris	vulgaris	NOUN
dpc-2776	30	6	patients	patient	NOUN
dpc-2776	30	7	,	,	PUNCT
dpc-2776	30	8	aged	age	VERB
dpc-2776	30	9	between	between	ADP
dpc-2776	30	10	13	13	NUM
dpc-2776	30	11	to	to	PART
dpc-2776	30	12	40	40	NUM
dpc-2776	30	13	years	year	NOUN
dpc-2776	30	14	,	,	PUNCT
dpc-2776	30	15	who	who	PRON
dpc-2776	30	16	have	have	AUX
dpc-2776	30	17	at	at	ADV
dpc-2776	30	18	least	least	ADJ
dpc-2776	30	19	received	receive	VERB
dpc-2776	30	20	one	one	NUM
dpc-2776	30	21	month	month	NOUN
dpc-2776	30	22	of	of	ADP
dpc-2776	30	23	oral	oral	ADJ
dpc-2776	30	24	isotretinoin	isotretinoin	PROPN
dpc-2776	30	25	treatment	treatment	NOUN
dpc-2776	30	26	in	in	ADP
dpc-2776	30	27	the	the	DET
dpc-2776	30	28	dermatology	dermatology	NOUN
dpc-2776	30	29	outpatient	outpatient	NOUN
dpc-2776	30	30	clinic	clinic	NOUN
dpc-2776	30	31	of	of	ADP
dpc-2776	30	32	zonguldak	zonguldak	PROPN
dpc-2776	30	33	atatürk	atatürk	PROPN
dpc-2776	30	34	state	state	PROPN
dpc-2776	30	35	hospital	hospital	NOUN
dpc-2776	30	36	and	and	CCONJ
dpc-2776	30	37	who	who	PRON
dpc-2776	30	38	were	be	AUX
dpc-2776	30	39	willing	willing	ADJ
dpc-2776	30	40	to	to	PART
dpc-2776	30	41	participate	participate	VERB
dpc-2776	30	42	in	in	ADP
dpc-2776	30	43	this	this	DET
dpc-2776	30	44	study	study	NOUN
dpc-2776	30	45	were	be	AUX
dpc-2776	30	46	included	include	VERB
dpc-2776	30	47	in	in	ADP
dpc-2776	30	48	this	this	DET
dpc-2776	30	49	cross	cross	ADJ
dpc-2776	30	50	-	-	ADJ
dpc-2776	30	51	sectional	sectional	ADJ
dpc-2776	30	52	study	study	NOUN
dpc-2776	30	53	.	.	PUNCT
dpc-2776	31	1	patients	patient	NOUN
dpc-2776	31	2	with	with	ADP
dpc-2776	31	3	already	already	ADV
dpc-2776	31	4	diagnosed	diagnose	VERB
dpc-2776	31	5	rheumatic	rheumatic	ADJ
dpc-2776	31	6	diseases	disease	NOUN
dpc-2776	31	7	,	,	PUNCT
dpc-2776	31	8	musculoskeletal	musculoskeletal	ADJ
dpc-2776	31	9	diseases	disease	NOUN
dpc-2776	31	10	,	,	PUNCT
dpc-2776	31	11	inflammatory	inflammatory	ADJ
dpc-2776	31	12	bowel	bowel	NOUN
dpc-2776	31	13	disease	disease	NOUN
dpc-2776	31	14	,	,	PUNCT
dpc-2776	31	15	hormonal	hormonal	ADJ
dpc-2776	31	16	disturbances	disturbance	NOUN
dpc-2776	31	17	,	,	PUNCT
dpc-2776	31	18	psychiatric	psychiatric	ADJ
dpc-2776	31	19	comorbidities	comorbiditie	NOUN
dpc-2776	31	20	and	and	CCONJ
dpc-2776	31	21	who	who	PRON
dpc-2776	31	22	were	be	AUX
dpc-2776	31	23	using	use	VERB
dpc-2776	31	24	non	non	ADJ
dpc-2776	31	25	-	-	ADJ
dpc-2776	31	26	steroidal	steroidal	ADJ
dpc-2776	31	27	anti	anti	ADJ
dpc-2776	31	28	-	-	ADJ
dpc-2776	31	29	inflammatory	inflammatory	ADJ
dpc-2776	31	30	drugs	drug	NOUN
dpc-2776	31	31	regularly	regularly	ADV
dpc-2776	31	32	were	be	AUX
dpc-2776	31	33	excluded	exclude	VERB
dpc-2776	31	34	from	from	ADP
dpc-2776	31	35	this	this	DET
dpc-2776	31	36	study	study	NOUN
dpc-2776	31	37	.	.	PUNCT
dpc-2776	32	1	data	datum	NOUN
dpc-2776	32	2	acquisition	acquisition	VERB
dpc-2776	32	3	the	the	DET
dpc-2776	32	4	blood	blood	NOUN
dpc-2776	32	5	chemistry	chemistry	NOUN
dpc-2776	32	6	including	include	VERB
dpc-2776	32	7	lipids	lipid	NOUN
dpc-2776	32	8	and	and	CCONJ
dpc-2776	32	9	beta	beta	NOUN
dpc-2776	32	10	-	-	PUNCT
dpc-2776	32	11	human	human	ADJ
dpc-2776	32	12	chorionic	chorionic	ADJ
dpc-2776	32	13	globulin	globulin	NOUN
dpc-2776	32	14	(	(	PUNCT
dpc-2776	32	15	for	for	ADP
dpc-2776	32	16	female	female	ADJ
dpc-2776	32	17	patients	patient	NOUN
dpc-2776	32	18	only	only	ADV
dpc-2776	32	19	)	)	PUNCT
dpc-2776	32	20	of	of	ADP
dpc-2776	32	21	the	the	DET
dpc-2776	32	22	patients	patient	NOUN
dpc-2776	32	23	receiving	receive	VERB
dpc-2776	32	24	oral	oral	ADJ
dpc-2776	32	25	isotretinoin	isotretinoin	PROPN
dpc-2776	32	26	were	be	AUX
dpc-2776	32	27	evaluated	evaluate	VERB
dpc-2776	32	28	during	during	ADP
dpc-2776	32	29	monthly	monthly	ADJ
dpc-2776	32	30	consultations	consultation	NOUN
dpc-2776	32	31	.	.	PUNCT
dpc-2776	33	1	the	the	DET
dpc-2776	33	2	age	age	NOUN
dpc-2776	33	3	,	,	PUNCT
dpc-2776	33	4	gender	gender	NOUN
dpc-2776	33	5	,	,	PUNCT
dpc-2776	33	6	isotretinoin	isotretinoin	PROPN
dpc-2776	33	7	dosage	dosage	NOUN
dpc-2776	33	8	(	(	PUNCT
dpc-2776	33	9	mg	mg	NOUN
dpc-2776	33	10	/	/	SYM
dpc-2776	33	11	kg/	kg/	NOUN
dpc-2776	33	12	day	day	PROPN
dpc-2776	33	13	)	)	PUNCT
dpc-2776	33	14	,	,	PUNCT
dpc-2776	33	15	treatment	treatment	NOUN
dpc-2776	33	16	duration	duration	NOUN
dpc-2776	33	17	(	(	PUNCT
dpc-2776	33	18	weeks	week	NOUN
dpc-2776	33	19	)	)	PUNCT
dpc-2776	33	20	and	and	CCONJ
dpc-2776	33	21	whether	whether	SCONJ
dpc-2776	33	22	the	the	DET
dpc-2776	33	23	patient	patient	NOUN
dpc-2776	33	24	is	be	AUX
dpc-2776	33	25	using	use	VERB
dpc-2776	33	26	isotretinoin	isotretinoin	PROPN
dpc-2776	33	27	the	the	DET
dpc-2776	33	28	first	first	ADJ
dpc-2776	33	29	or	or	CCONJ
dpc-2776	33	30	the	the	DET
dpc-2776	33	31	second	second	ADJ
dpc-2776	33	32	time	time	NOUN
dpc-2776	33	33	for	for	ADP
dpc-2776	33	34	acne	acne	NOUN
dpc-2776	33	35	vulgaris	vulgaris	NOUN
dpc-2776	33	36	were	be	AUX
dpc-2776	33	37	noted	note	VERB
dpc-2776	33	38	during	during	ADP
dpc-2776	33	39	the	the	DET
dpc-2776	33	40	monthly	monthly	ADJ
dpc-2776	33	41	consultations	consultation	NOUN
dpc-2776	33	42	.	.	PUNCT
dpc-2776	34	1	the	the	DET
dpc-2776	34	2	patients	patient	NOUN
dpc-2776	34	3	were	be	AUX
dpc-2776	34	4	questioned	question	VERB
dpc-2776	34	5	for	for	ADP
dpc-2776	34	6	the	the	DET
dpc-2776	34	7	presence	presence	NOUN
dpc-2776	34	8	of	of	ADP
dpc-2776	34	9	fatigue	fatigue	NOUN
dpc-2776	34	10	,	,	PUNCT
dpc-2776	34	11	myalgia	myalgia	NOUN
dpc-2776	34	12	or	or	CCONJ
dpc-2776	34	13	low	low	ADJ
dpc-2776	34	14	back	back	ADJ
dpc-2776	34	15	pain	pain	NOUN
dpc-2776	34	16	;	;	PUNCT
dpc-2776	34	17	and	and	CCONJ
dpc-2776	34	18	the	the	DET
dpc-2776	34	19	patients	patient	NOUN
dpc-2776	34	20	with	with	ADP
dpc-2776	34	21	low	low	ADJ
dpc-2776	34	22	back	back	ADJ
dpc-2776	34	23	pain	pain	NOUN
dpc-2776	34	24	were	be	AUX
dpc-2776	34	25	referred	refer	VERB
dpc-2776	34	26	to	to	ADP
dpc-2776	34	27	the	the	DET
dpc-2776	34	28	physical	physical	ADJ
dpc-2776	34	29	therapy	therapy	NOUN
dpc-2776	34	30	and	and	CCONJ
dpc-2776	34	31	rehabilitation	rehabilitation	NOUN
dpc-2776	34	32	outpatient	outpatient	NOUN
dpc-2776	34	33	clinic	clinic	NOUN
dpc-2776	34	34	for	for	ADP
dpc-2776	34	35	further	further	ADJ
dpc-2776	34	36	evaluation	evaluation	NOUN
dpc-2776	34	37	.	.	PUNCT
dpc-2776	35	1	the	the	DET
dpc-2776	35	2	physical	physical	ADJ
dpc-2776	35	3	therapy	therapy	NOUN
dpc-2776	35	4	and	and	CCONJ
dpc-2776	35	5	rehabilitation	rehabilitation	NOUN
dpc-2776	35	6	specialist	specialist	NOUN
dpc-2776	35	7	has	have	AUX
dpc-2776	35	8	evaluated	evaluate	VERB
dpc-2776	35	9	the	the	DET
dpc-2776	35	10	patients	patient	NOUN
dpc-2776	35	11	to	to	PART
dpc-2776	35	12	determine	determine	VERB
dpc-2776	35	13	the	the	DET
dpc-2776	35	14	character	character	NOUN
dpc-2776	35	15	of	of	ADP
dpc-2776	35	16	low	low	ADJ
dpc-2776	35	17	back	back	ADJ
dpc-2776	35	18	pain	pain	NOUN
dpc-2776	35	19	(	(	PUNCT
dpc-2776	35	20	inflammatory	inflammatory	ADJ
dpc-2776	35	21	or	or	CCONJ
dpc-2776	35	22	mechanical	mechanical	ADJ
dpc-2776	35	23	)	)	PUNCT
dpc-2776	35	24	along	along	ADP
dpc-2776	35	25	with	with	ADP
dpc-2776	35	26	performing	perform	VERB
dpc-2776	35	27	physical	physical	ADJ
dpc-2776	35	28	examination	examination	NOUN
dpc-2776	35	29	of	of	ADP
dpc-2776	35	30	the	the	DET
dpc-2776	35	31	range	range	NOUN
dpc-2776	35	32	of	of	ADP
dpc-2776	35	33	motion	motion	NOUN
dpc-2776	35	34	,	,	PUNCT
dpc-2776	35	35	muscle	muscle	NOUN
dpc-2776	35	36	power	power	NOUN
dpc-2776	35	37	and	and	CCONJ
dpc-2776	35	38	lordosis	lordosis	NOUN
dpc-2776	35	39	.	.	PUNCT
dpc-2776	36	1	magnetic	magnetic	ADJ
dpc-2776	36	2	resonance	resonance	NOUN
dpc-2776	36	3	imaging	imaging	NOUN
dpc-2776	36	4	of	of	ADP
dpc-2776	36	5	the	the	DET
dpc-2776	36	6	lumber	lumber	NOUN
dpc-2776	36	7	vertebrae	vertebrae	NOUN
dpc-2776	36	8	was	be	AUX
dpc-2776	36	9	performed	perform	VERB
dpc-2776	36	10	on	on	ADP
dpc-2776	36	11	the	the	DET
dpc-2776	36	12	patients	patient	NOUN
dpc-2776	36	13	who	who	PRON
dpc-2776	36	14	had	have	VERB
dpc-2776	36	15	inflammatory	inflammatory	ADJ
dpc-2776	36	16	low	low	ADJ
dpc-2776	36	17	back	back	ADJ
dpc-2776	36	18	pain	pain	NOUN
dpc-2776	36	19	in	in	ADP
dpc-2776	36	20	order	order	NOUN
dpc-2776	36	21	to	to	PART
dpc-2776	36	22	evaluate	evaluate	VERB
dpc-2776	36	23	sacroiliitis	sacroiliitis	NOUN
dpc-2776	36	24	.	.	PUNCT
dpc-2776	37	1	statistical	statistical	ADJ
dpc-2776	37	2	analysis	analysis	NOUN
dpc-2776	37	3	spss	spss	PROPN
dpc-2776	37	4	version	version	NOUN
dpc-2776	37	5	21	21	NUM
dpc-2776	37	6	was	be	AUX
dpc-2776	37	7	used	use	VERB
dpc-2776	37	8	for	for	ADP
dpc-2776	37	9	the	the	DET
dpc-2776	37	10	statistical	statistical	ADJ
dpc-2776	37	11	analyses	analysis	NOUN
dpc-2776	37	12	.	.	PUNCT
dpc-2776	38	1	mann	mann	PROPN
dpc-2776	38	2	-	-	PUNCT
dpc-2776	38	3	whitney	whitney	PROPN
dpc-2776	38	4	u	u	PROPN
dpc-2776	38	5	test	test	NOUN
dpc-2776	38	6	was	be	AUX
dpc-2776	38	7	used	use	VERB
dpc-2776	38	8	to	to	PART
dpc-2776	38	9	determine	determine	VERB
dpc-2776	38	10	the	the	DET
dpc-2776	38	11	relationship	relationship	NOUN
dpc-2776	38	12	of	of	ADP
dpc-2776	38	13	age	age	NOUN
dpc-2776	38	14	,	,	PUNCT
dpc-2776	38	15	isotretinoin	isotretinoin	PROPN
dpc-2776	38	16	dosage	dosage	NOUN
dpc-2776	38	17	and	and	CCONJ
dpc-2776	38	18	treatment	treatment	NOUN
dpc-2776	38	19	duration	duration	NOUN
dpc-2776	38	20	to	to	ADP
dpc-2776	38	21	all	all	PRON
dpc-2776	38	22	of	of	ADP
dpc-2776	38	23	the	the	DET
dpc-2776	38	24	side	side	NOUN
dpc-2776	38	25	effects	effect	NOUN
dpc-2776	38	26	studied	study	VERB
dpc-2776	38	27	(	(	PUNCT
dpc-2776	38	28	fatigue	fatigue	NOUN
dpc-2776	38	29	,	,	PUNCT
dpc-2776	38	30	myalgia	myalgia	NOUN
dpc-2776	38	31	and	and	CCONJ
dpc-2776	38	32	low	low	ADJ
dpc-2776	38	33	back	back	ADJ
dpc-2776	38	34	pain	pain	NOUN
dpc-2776	38	35	)	)	PUNCT
dpc-2776	38	36	.	.	PUNCT
dpc-2776	39	1	pearson	pearson	PROPN
dpc-2776	39	2	chi	chi	PROPN
dpc-2776	39	3	-	-	PUNCT
dpc-2776	39	4	square	square	PROPN
dpc-2776	39	5	test	test	NOUN
dpc-2776	39	6	was	be	AUX
dpc-2776	39	7	used	use	VERB
dpc-2776	39	8	to	to	PART
dpc-2776	39	9	determine	determine	VERB
dpc-2776	39	10	the	the	DET
dpc-2776	39	11	relationship	relationship	NOUN
dpc-2776	39	12	of	of	ADP
dpc-2776	39	13	gender	gender	NOUN
dpc-2776	39	14	to	to	ADP
dpc-2776	39	15	fatigue	fatigue	NOUN
dpc-2776	39	16	and	and	CCONJ
dpc-2776	39	17	low	low	ADJ
dpc-2776	39	18	back	back	ADJ
dpc-2776	39	19	pain	pain	NOUN
dpc-2776	39	20	;	;	PUNCT
dpc-2776	39	21	and	and	CCONJ
dpc-2776	39	22	of	of	ADP
dpc-2776	39	23	isotretinoin	isotretinoin	PROPN
dpc-2776	39	24	-	-	PUNCT
dpc-2776	39	25	naiveness	naiveness	NOUN
dpc-2776	39	26	to	to	ADP
dpc-2776	39	27	low	low	ADJ
dpc-2776	39	28	back	back	ADJ
dpc-2776	39	29	pain	pain	NOUN
dpc-2776	39	30	.	.	PUNCT
dpc-2776	40	1	fisher	fisher	PROPN
dpc-2776	40	2	exact	exact	PROPN
dpc-2776	40	3	test	test	NOUN
dpc-2776	40	4	was	be	AUX
dpc-2776	40	5	used	use	VERB
dpc-2776	40	6	to	to	PART
dpc-2776	40	7	determine	determine	VERB
dpc-2776	40	8	the	the	DET
dpc-2776	40	9	relationship	relationship	NOUN
dpc-2776	40	10	of	of	ADP
dpc-2776	40	11	gender	gender	NOUN
dpc-2776	40	12	to	to	ADP
dpc-2776	40	13	myalgia	myalgia	NOUN
dpc-2776	40	14	;	;	PUNCT
dpc-2776	40	15	and	and	CCONJ
dpc-2776	40	16	of	of	ADP
dpc-2776	40	17	isotretinoin	isotretinoin	PROPN
dpc-2776	40	18	-	-	PUNCT
dpc-2776	40	19	naiveness	naiveness	NOUN
dpc-2776	40	20	to	to	ADP
dpc-2776	40	21	fatigue	fatigue	NOUN
dpc-2776	40	22	and	and	CCONJ
dpc-2776	40	23	myalgia	myalgia	NOUN
dpc-2776	40	24	.	.	PUNCT
dpc-2776	41	1	ethics	ethic	NOUN
dpc-2776	41	2	the	the	DET
dpc-2776	41	3	approval	approval	NOUN
dpc-2776	41	4	of	of	ADP
dpc-2776	41	5	i̇stanbul	i̇stanbul	PROPN
dpc-2776	41	6	kent	kent	PROPN
dpc-2776	41	7	university	university	PROPN
dpc-2776	41	8	ethics	ethic	NOUN
dpc-2776	41	9	committee	committee	PROPN
dpc-2776	41	10	was	be	AUX
dpc-2776	41	11	obtained	obtain	VERB
dpc-2776	41	12	before	before	ADP
dpc-2776	41	13	the	the	DET
dpc-2776	41	14	initiation	initiation	NOUN
dpc-2776	41	15	of	of	ADP
dpc-2776	41	16	the	the	DET
dpc-2776	41	17	study	study	NOUN
dpc-2776	41	18	(	(	PUNCT
dpc-2776	41	19	27.05.2022	27.05.2022	NOUN
dpc-2776	41	20	)	)	PUNCT
dpc-2776	41	21	.	.	PUNCT
dpc-2776	42	1	informed	informed	ADJ
dpc-2776	42	2	consent	consent	NOUN
dpc-2776	42	3	was	be	AUX
dpc-2776	42	4	taken	take	VERB
dpc-2776	42	5	from	from	ADP
dpc-2776	42	6	all	all	PRON
dpc-2776	42	7	of	of	ADP
dpc-2776	42	8	the	the	DET
dpc-2776	42	9	patients	patient	NOUN
dpc-2776	42	10	who	who	PRON
dpc-2776	42	11	were	be	AUX
dpc-2776	42	12	willing	willing	ADJ
dpc-2776	42	13	to	to	PART
dpc-2776	42	14	participate	participate	VERB
dpc-2776	42	15	in	in	ADP
dpc-2776	42	16	this	this	DET
dpc-2776	42	17	study	study	NOUN
dpc-2776	42	18	;	;	PUNCT
dpc-2776	42	19	and	and	CCONJ
dpc-2776	42	20	the	the	DET
dpc-2776	42	21	study	study	NOUN
dpc-2776	42	22	was	be	AUX
dpc-2776	42	23	conducted	conduct	VERB
dpc-2776	42	24	in	in	ADP
dpc-2776	42	25	accordance	accordance	NOUN
dpc-2776	42	26	with	with	ADP
dpc-2776	42	27	the	the	DET
dpc-2776	42	28	helsinki	helsinki	PROPN
dpc-2776	42	29	declaration	declaration	PROPN
dpc-2776	42	30	.	.	PUNCT
dpc-2776	43	1	results	result	VERB
dpc-2776	43	2	patient	patient	ADJ
dpc-2776	43	3	characteristics	characteristic	NOUN
dpc-2776	43	4	and	and	CCONJ
dpc-2776	43	5	side	side	NOUN
dpc-2776	43	6	effects	effect	NOUN
dpc-2776	43	7	a	a	DET
dpc-2776	43	8	total	total	NOUN
dpc-2776	43	9	of	of	ADP
dpc-2776	43	10	180	180	NUM
dpc-2776	43	11	patients	patient	NOUN
dpc-2776	43	12	were	be	AUX
dpc-2776	43	13	included	include	VERB
dpc-2776	43	14	in	in	ADP
dpc-2776	43	15	this	this	DET
dpc-2776	43	16	study	study	NOUN
dpc-2776	43	17	.	.	PUNCT
dpc-2776	44	1	the	the	DET
dpc-2776	44	2	mean	mean	ADJ
dpc-2776	44	3	age	age	NOUN
dpc-2776	44	4	of	of	ADP
dpc-2776	44	5	the	the	DET
dpc-2776	44	6	patients	patient	NOUN
dpc-2776	44	7	was	be	AUX
dpc-2776	44	8	20.3	20.3	NUM
dpc-2776	44	9	years	year	NOUN
dpc-2776	44	10	with	with	ADP
dpc-2776	44	11	a	a	DET
dpc-2776	44	12	standard	standard	ADJ
dpc-2776	44	13	deviation	deviation	NOUN
dpc-2776	44	14	of	of	ADP
dpc-2776	44	15	5	5	NUM
dpc-2776	44	16	years	year	NOUN
dpc-2776	44	17	.	.	PUNCT
dpc-2776	45	1	of	of	ADP
dpc-2776	45	2	all	all	DET
dpc-2776	45	3	the	the	DET
dpc-2776	45	4	patients	patient	NOUN
dpc-2776	45	5	,	,	PUNCT
dpc-2776	45	6	57	57	NUM
dpc-2776	45	7	(	(	PUNCT
dpc-2776	45	8	31.7	31.7	NUM
dpc-2776	45	9	%	%	NOUN
dpc-2776	45	10	)	)	PUNCT
dpc-2776	45	11	were	be	AUX
dpc-2776	45	12	male	male	ADJ
dpc-2776	45	13	and	and	CCONJ
dpc-2776	45	14	123	123	NUM
dpc-2776	45	15	(	(	PUNCT
dpc-2776	45	16	68.3	68.3	NUM
dpc-2776	45	17	%	%	NOUN
dpc-2776	45	18	)	)	PUNCT
dpc-2776	45	19	were	be	AUX
dpc-2776	45	20	female	female	ADJ
dpc-2776	45	21	.	.	PUNCT
dpc-2776	46	1	fatigue	fatigue	NOUN
dpc-2776	46	2	was	be	AUX
dpc-2776	46	3	reported	report	VERB
dpc-2776	46	4	by	by	ADP
dpc-2776	46	5	8	8	NUM
dpc-2776	46	6	(	(	PUNCT
dpc-2776	46	7	4.4	4.4	NUM
dpc-2776	46	8	%	%	NOUN
dpc-2776	46	9	)	)	PUNCT
dpc-2776	46	10	of	of	ADP
dpc-2776	46	11	the	the	DET
dpc-2776	46	12	patients	patient	NOUN
dpc-2776	46	13	,	,	PUNCT
dpc-2776	46	14	myalgia	myalgia	NOUN
dpc-2776	46	15	by	by	ADP
dpc-2776	46	16	5	5	NUM
dpc-2776	46	17	(	(	PUNCT
dpc-2776	46	18	2.8	2.8	NUM
dpc-2776	46	19	%	%	NOUN
dpc-2776	46	20	)	)	PUNCT
dpc-2776	46	21	and	and	CCONJ
dpc-2776	46	22	low	low	ADJ
dpc-2776	46	23	back	back	ADJ
dpc-2776	46	24	pain	pain	NOUN
dpc-2776	46	25	by	by	ADP
dpc-2776	46	26	45	45	NUM
dpc-2776	46	27	(	(	PUNCT
dpc-2776	46	28	25	25	NUM
dpc-2776	46	29	%	%	NOUN
dpc-2776	46	30	)	)	PUNCT
dpc-2776	46	31	of	of	ADP
dpc-2776	46	32	the	the	DET
dpc-2776	46	33	patients	patient	NOUN
dpc-2776	46	34	.	.	PUNCT
dpc-2776	47	1	four	four	NUM
dpc-2776	47	2	(	(	PUNCT
dpc-2776	47	3	2.2	2.2	NUM
dpc-2776	47	4	%	%	NOUN
dpc-2776	47	5	)	)	PUNCT
dpc-2776	47	6	of	of	ADP
dpc-2776	47	7	the	the	DET
dpc-2776	47	8	patients	patient	NOUN
dpc-2776	47	9	were	be	AUX
dpc-2776	47	10	diagnosed	diagnose	VERB
dpc-2776	47	11	with	with	ADP
dpc-2776	47	12	inflammatory	inflammatory	ADJ
dpc-2776	47	13	low	low	ADJ
dpc-2776	47	14	back	back	ADJ
dpc-2776	47	15	pain	pain	NOUN
dpc-2776	47	16	by	by	ADP
dpc-2776	47	17	the	the	DET
dpc-2776	47	18	physical	physical	ADJ
dpc-2776	47	19	therapy	therapy	NOUN
dpc-2776	47	20	and	and	CCONJ
dpc-2776	47	21	rehabilitation	rehabilitation	NOUN
dpc-2776	47	22	specialist	specialist	NOUN
dpc-2776	47	23	;	;	PUNCT
dpc-2776	47	24	and	and	CCONJ
dpc-2776	47	25	41	41	NUM
dpc-2776	47	26	(	(	PUNCT
dpc-2776	47	27	22.8	22.8	NUM
dpc-2776	47	28	%	%	NOUN
dpc-2776	47	29	)	)	PUNCT
dpc-2776	47	30	were	be	AUX
dpc-2776	47	31	had	have	VERB
dpc-2776	47	32	sacroiliitis	sacroiliitis	ADJ
dpc-2776	47	33	.	.	PUNCT
dpc-2776	48	1	all	all	DET
dpc-2776	48	2	the	the	DET
dpc-2776	48	3	side	side	NOUN
dpc-2776	48	4	effects	effect	NOUN
dpc-2776	48	5	that	that	PRON
dpc-2776	48	6	were	be	AUX
dpc-2776	48	7	examined	examine	VERB
dpc-2776	48	8	were	be	AUX
dpc-2776	48	9	found	find	VERB
dpc-2776	48	10	to	to	PART
dpc-2776	48	11	be	be	AUX
dpc-2776	48	12	independent	independent	ADJ
dpc-2776	48	13	of	of	ADP
dpc-2776	48	14	age	age	NOUN
dpc-2776	48	15	,	,	PUNCT
dpc-2776	48	16	gender	gender	NOUN
dpc-2776	48	17	,	,	PUNCT
dpc-2776	48	18	isotretinoin	isotretinoin	PROPN
dpc-2776	48	19	dosage	dosage	NOUN
dpc-2776	48	20	(	(	PUNCT
dpc-2776	48	21	mg	mg	PROPN
dpc-2776	48	22	/	/	SYM
dpc-2776	48	23	kg	kg	PROPN
dpc-2776	48	24	/	/	SYM
dpc-2776	48	25	day	day	NOUN
dpc-2776	48	26	)	)	PUNCT
dpc-2776	48	27	,	,	PUNCT
dpc-2776	48	28	treatment	treatment	NOUN
dpc-2776	48	29	duration	duration	NOUN
dpc-2776	48	30	and	and	CCONJ
dpc-2776	48	31	isotretinoin	isotretinoin	NOUN
dpc-2776	48	32	-	-	PUNCT
dpc-2776	48	33	naiveness	naiveness	NOUN
dpc-2776	48	34	.	.	PUNCT
dpc-2776	49	1	conclusions	conclusion	NOUN
dpc-2776	49	2	:	:	PUNCT
dpc-2776	49	3	the	the	DET
dpc-2776	49	4	side	side	NOUN
dpc-2776	49	5	effects	effect	NOUN
dpc-2776	49	6	are	be	AUX
dpc-2776	49	7	not	not	PART
dpc-2776	49	8	as	as	ADV
dpc-2776	49	9	common	common	ADJ
dpc-2776	49	10	as	as	SCONJ
dpc-2776	49	11	feared	fear	VERB
dpc-2776	49	12	;	;	PUNCT
dpc-2776	49	13	thus	thus	ADV
dpc-2776	49	14	,	,	PUNCT
dpc-2776	49	15	patients	patient	NOUN
dpc-2776	49	16	and	and	CCONJ
dpc-2776	49	17	physicians	physician	NOUN
dpc-2776	49	18	should	should	AUX
dpc-2776	49	19	not	not	PART
dpc-2776	49	20	hesitate	hesitate	VERB
dpc-2776	49	21	to	to	PART
dpc-2776	49	22	use	use	VERB
dpc-2776	49	23	systemic	systemic	ADJ
dpc-2776	49	24	isotretinoin	isotretinoin	NOUN
dpc-2776	49	25	in	in	ADP
dpc-2776	49	26	indicated	indicate	VERB
dpc-2776	49	27	cases	case	NOUN
dpc-2776	49	28	.	.	PUNCT
dpc-2776	50	1	original	original	ADJ
dpc-2776	50	2	article	article	NOUN
dpc-2776	50	3	|	|	ADV
dpc-2776	50	4	dermatol	dermatol	ADJ
dpc-2776	50	5	pract	pract	NOUN
dpc-2776	50	6	concept	concept	NOUN
dpc-2776	50	7	.	.	PUNCT
dpc-2776	51	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	51	2	3	3	NUM
dpc-2776	51	3	diagnosed	diagnose	VERB
dpc-2776	51	4	with	with	ADP
dpc-2776	51	5	mechanical	mechanical	ADJ
dpc-2776	51	6	low	low	ADJ
dpc-2776	51	7	back	back	ADJ
dpc-2776	51	8	pain	pain	NOUN
dpc-2776	51	9	.	.	PUNCT
dpc-2776	52	1	the	the	DET
dpc-2776	52	2	mean	mean	ADJ
dpc-2776	52	3	isotretinoin	isotretinoin	PROPN
dpc-2776	52	4	treatment	treatment	NOUN
dpc-2776	52	5	duration	duration	NOUN
dpc-2776	52	6	was	be	AUX
dpc-2776	52	7	9.6	9.6	NUM
dpc-2776	52	8	weeks	week	NOUN
dpc-2776	52	9	with	with	ADP
dpc-2776	52	10	a	a	DET
dpc-2776	52	11	standard	standard	ADJ
dpc-2776	52	12	deviation	deviation	NOUN
dpc-2776	52	13	of	of	ADP
dpc-2776	52	14	6.7	6.7	NUM
dpc-2776	52	15	weeks	week	NOUN
dpc-2776	52	16	;	;	PUNCT
dpc-2776	52	17	the	the	DET
dpc-2776	52	18	mean	mean	ADJ
dpc-2776	52	19	isotretinoin	isotretinoin	PROPN
dpc-2776	52	20	dosage	dosage	NOUN
dpc-2776	52	21	was	be	AUX
dpc-2776	52	22	0.582	0.582	NUM
dpc-2776	52	23	mg	mg	PROPN
dpc-2776	52	24	/	/	SYM
dpc-2776	52	25	kg	kg	PROPN
dpc-2776	52	26	/	/	SYM
dpc-2776	52	27	day	day	NOUN
dpc-2776	52	28	with	with	ADP
dpc-2776	52	29	a	a	DET
dpc-2776	52	30	standard	standard	ADJ
dpc-2776	52	31	deviation	deviation	NOUN
dpc-2776	52	32	of	of	ADP
dpc-2776	52	33	0.18	0.18	NUM
dpc-2776	52	34	mg	mg	PROPN
dpc-2776	52	35	/	/	SYM
dpc-2776	52	36	kg	kg	PROPN
dpc-2776	52	37	/	/	SYM
dpc-2776	52	38	day	day	NOUN
dpc-2776	52	39	;	;	PUNCT
dpc-2776	52	40	and	and	CCONJ
dpc-2776	52	41	144	144	NUM
dpc-2776	52	42	(	(	PUNCT
dpc-2776	52	43	80	80	NUM
dpc-2776	52	44	%	%	NOUN
dpc-2776	52	45	)	)	PUNCT
dpc-2776	52	46	of	of	ADP
dpc-2776	52	47	the	the	DET
dpc-2776	52	48	patients	patient	NOUN
dpc-2776	52	49	were	be	AUX
dpc-2776	52	50	isotretinoin	isotretinoin	PROPN
dpc-2776	52	51	-	-	PUNCT
dpc-2776	52	52	naïve	naïve	ADJ
dpc-2776	52	53	,	,	PUNCT
dpc-2776	52	54	whereas	whereas	SCONJ
dpc-2776	52	55	36	36	NUM
dpc-2776	52	56	(	(	PUNCT
dpc-2776	52	57	20	20	NUM
dpc-2776	52	58	%	%	NOUN
dpc-2776	52	59	)	)	PUNCT
dpc-2776	52	60	were	be	AUX
dpc-2776	52	61	using	use	VERB
dpc-2776	52	62	isotretinoin	isotretinoin	PROPN
dpc-2776	52	63	for	for	ADP
dpc-2776	52	64	the	the	DET
dpc-2776	52	65	second	second	ADJ
dpc-2776	52	66	time	time	NOUN
dpc-2776	52	67	.	.	PUNCT
dpc-2776	53	1	patient	patient	ADJ
dpc-2776	53	2	characteristics	characteristic	NOUN
dpc-2776	53	3	and	and	CCONJ
dpc-2776	53	4	side	side	NOUN
dpc-2776	53	5	effects	effect	NOUN
dpc-2776	53	6	are	be	AUX
dpc-2776	53	7	summarized	summarize	VERB
dpc-2776	53	8	in	in	ADP
dpc-2776	53	9	table	table	NOUN
dpc-2776	53	10	1	1	NUM
dpc-2776	53	11	.	.	PUNCT
dpc-2776	53	12	relationship	relationship	NOUN
dpc-2776	53	13	of	of	ADP
dpc-2776	53	14	side	side	NOUN
dpc-2776	53	15	effects	effect	NOUN
dpc-2776	53	16	to	to	ADP
dpc-2776	53	17	patient	patient	ADJ
dpc-2776	53	18	characteristics	characteristic	NOUN
dpc-2776	53	19	fatigue	fatigue	NOUN
dpc-2776	53	20	,	,	PUNCT
dpc-2776	53	21	myalgia	myalgia	NOUN
dpc-2776	53	22	and	and	CCONJ
dpc-2776	53	23	low	low	ADJ
dpc-2776	53	24	back	back	ADJ
dpc-2776	53	25	pain	pain	NOUN
dpc-2776	53	26	were	be	AUX
dpc-2776	53	27	the	the	DET
dpc-2776	53	28	side	side	NOUN
dpc-2776	53	29	effects	effect	NOUN
dpc-2776	53	30	that	that	PRON
dpc-2776	53	31	were	be	AUX
dpc-2776	53	32	examined	examine	VERB
dpc-2776	53	33	in	in	ADP
dpc-2776	53	34	this	this	DET
dpc-2776	53	35	study	study	NOUN
dpc-2776	53	36	.	.	PUNCT
dpc-2776	54	1	all	all	PRON
dpc-2776	54	2	of	of	ADP
dpc-2776	54	3	the	the	DET
dpc-2776	54	4	side	side	NOUN
dpc-2776	54	5	effects	effect	NOUN
dpc-2776	54	6	that	that	PRON
dpc-2776	54	7	were	be	AUX
dpc-2776	54	8	examined	examine	VERB
dpc-2776	54	9	were	be	AUX
dpc-2776	54	10	found	find	VERB
dpc-2776	54	11	to	to	PART
dpc-2776	54	12	be	be	AUX
dpc-2776	54	13	independent	independent	ADJ
dpc-2776	54	14	of	of	ADP
dpc-2776	54	15	age	age	NOUN
dpc-2776	54	16	,	,	PUNCT
dpc-2776	54	17	gender	gender	NOUN
dpc-2776	54	18	,	,	PUNCT
dpc-2776	54	19	isotretinoin	isotretinoin	PROPN
dpc-2776	54	20	dosage	dosage	NOUN
dpc-2776	54	21	(	(	PUNCT
dpc-2776	54	22	mg	mg	PROPN
dpc-2776	54	23	/	/	SYM
dpc-2776	54	24	kg	kg	PROPN
dpc-2776	54	25	/	/	SYM
dpc-2776	54	26	day	day	NOUN
dpc-2776	54	27	)	)	PUNCT
dpc-2776	54	28	,	,	PUNCT
dpc-2776	54	29	treatment	treatment	NOUN
dpc-2776	54	30	duration	duration	NOUN
dpc-2776	54	31	and	and	CCONJ
dpc-2776	54	32	isotretinoin	isotretinoin	NOUN
dpc-2776	54	33	-	-	PUNCT
dpc-2776	54	34	naiveness	naiveness	NOUN
dpc-2776	54	35	.	.	PUNCT
dpc-2776	55	1	the	the	DET
dpc-2776	55	2	relationships	relationship	NOUN
dpc-2776	55	3	of	of	ADP
dpc-2776	55	4	side	side	NOUN
dpc-2776	55	5	effects	effect	NOUN
dpc-2776	55	6	to	to	ADP
dpc-2776	55	7	the	the	DET
dpc-2776	55	8	patient	patient	ADJ
dpc-2776	55	9	characteristics	characteristic	NOUN
dpc-2776	55	10	are	be	AUX
dpc-2776	55	11	summarized	summarize	VERB
dpc-2776	55	12	in	in	ADP
dpc-2776	55	13	table	table	NOUN
dpc-2776	55	14	2	2	NUM
dpc-2776	55	15	.	.	PUNCT
dpc-2776	55	16	character	character	NOUN
dpc-2776	55	17	of	of	ADP
dpc-2776	55	18	the	the	DET
dpc-2776	55	19	low	low	ADJ
dpc-2776	55	20	back	back	NOUN
dpc-2776	55	21	pain	pain	NOUN
dpc-2776	55	22	the	the	DET
dpc-2776	55	23	patients	patient	NOUN
dpc-2776	55	24	with	with	ADP
dpc-2776	55	25	low	low	ADJ
dpc-2776	55	26	back	back	ADJ
dpc-2776	55	27	pain	pain	NOUN
dpc-2776	55	28	were	be	AUX
dpc-2776	55	29	further	far	ADV
dpc-2776	55	30	examined	examine	VERB
dpc-2776	55	31	for	for	ADP
dpc-2776	55	32	the	the	DET
dpc-2776	55	33	character	character	NOUN
dpc-2776	55	34	of	of	ADP
dpc-2776	55	35	low	low	ADJ
dpc-2776	55	36	back	back	ADJ
dpc-2776	55	37	pain	pain	NOUN
dpc-2776	55	38	by	by	ADP
dpc-2776	55	39	the	the	DET
dpc-2776	55	40	physical	physical	ADJ
dpc-2776	55	41	therapy	therapy	NOUN
dpc-2776	55	42	and	and	CCONJ
dpc-2776	55	43	rehabilitation	rehabilitation	NOUN
dpc-2776	55	44	specialist	specialist	NOUN
dpc-2776	55	45	.	.	PUNCT
dpc-2776	56	1	within	within	ADP
dpc-2776	56	2	the	the	DET
dpc-2776	56	3	patients	patient	NOUN
dpc-2776	56	4	with	with	ADP
dpc-2776	56	5	low	low	ADJ
dpc-2776	56	6	back	back	ADJ
dpc-2776	56	7	pain	pain	NOUN
dpc-2776	56	8	,	,	PUNCT
dpc-2776	56	9	only	only	ADV
dpc-2776	56	10	4	4	NUM
dpc-2776	56	11	(	(	PUNCT
dpc-2776	56	12	8.9	8.9	NUM
dpc-2776	56	13	%	%	NOUN
dpc-2776	56	14	)	)	PUNCT
dpc-2776	56	15	had	have	VERB
dpc-2776	56	16	inflammatory	inflammatory	ADJ
dpc-2776	56	17	low	low	ADJ
dpc-2776	56	18	back	back	ADJ
dpc-2776	56	19	pain	pain	NOUN
dpc-2776	56	20	.	.	PUNCT
dpc-2776	57	1	there	there	PRON
dpc-2776	57	2	was	be	VERB
dpc-2776	57	3	no	no	DET
dpc-2776	57	4	statistically	statistically	ADV
dpc-2776	57	5	significant	significant	ADJ
dpc-2776	57	6	relationship	relationship	NOUN
dpc-2776	57	7	between	between	ADP
dpc-2776	57	8	the	the	DET
dpc-2776	57	9	age	age	NOUN
dpc-2776	57	10	of	of	ADP
dpc-2776	57	11	the	the	DET
dpc-2776	57	12	patient	patient	NOUN
dpc-2776	57	13	,	,	PUNCT
dpc-2776	57	14	gender	gender	NOUN
dpc-2776	57	15	of	of	ADP
dpc-2776	57	16	the	the	DET
dpc-2776	57	17	patient	patient	NOUN
dpc-2776	57	18	,	,	PUNCT
dpc-2776	57	19	isotretinoin	isotretinoin	PROPN
dpc-2776	57	20	dosage	dosage	NOUN
dpc-2776	57	21	(	(	PUNCT
dpc-2776	57	22	mg	mg	PROPN
dpc-2776	57	23	/	/	SYM
dpc-2776	57	24	kg	kg	PROPN
dpc-2776	57	25	/	/	SYM
dpc-2776	57	26	day	day	NOUN
dpc-2776	57	27	)	)	PUNCT
dpc-2776	57	28	,	,	PUNCT
dpc-2776	57	29	treatment	treatment	NOUN
dpc-2776	57	30	duration	duration	NOUN
dpc-2776	57	31	(	(	PUNCT
dpc-2776	57	32	weeks	week	NOUN
dpc-2776	57	33	)	)	PUNCT
dpc-2776	57	34	and	and	CCONJ
dpc-2776	57	35	isotretinoin	isotretinoin	PROPN
dpc-2776	57	36	naiveness	naiveness	NOUN
dpc-2776	57	37	of	of	ADP
dpc-2776	57	38	the	the	DET
dpc-2776	57	39	patient	patient	NOUN
dpc-2776	57	40	;	;	PUNCT
dpc-2776	57	41	and	and	CCONJ
dpc-2776	57	42	the	the	DET
dpc-2776	57	43	character	character	NOUN
dpc-2776	57	44	of	of	ADP
dpc-2776	57	45	low	low	ADJ
dpc-2776	57	46	back	back	ADJ
dpc-2776	57	47	pain	pain	NOUN
dpc-2776	57	48	.	.	PUNCT
dpc-2776	58	1	table	table	NOUN
dpc-2776	58	2	3	3	NUM
dpc-2776	58	3	summarizes	summarize	VERB
dpc-2776	58	4	the	the	DET
dpc-2776	58	5	relationship	relationship	NOUN
dpc-2776	58	6	of	of	ADP
dpc-2776	58	7	the	the	DET
dpc-2776	58	8	character	character	NOUN
dpc-2776	58	9	of	of	ADP
dpc-2776	58	10	low	low	ADJ
dpc-2776	58	11	back	back	ADJ
dpc-2776	58	12	pain	pain	NOUN
dpc-2776	58	13	to	to	ADP
dpc-2776	58	14	the	the	DET
dpc-2776	58	15	patient	patient	ADJ
dpc-2776	58	16	characteristics	characteristic	NOUN
dpc-2776	58	17	.	.	PUNCT
dpc-2776	59	1	table	table	NOUN
dpc-2776	59	2	1	1	NUM
dpc-2776	59	3	.	.	PUNCT
dpc-2776	60	1	patient	patient	ADJ
dpc-2776	60	2	characteristics	characteristic	NOUN
dpc-2776	60	3	and	and	CCONJ
dpc-2776	60	4	side	side	NOUN
dpc-2776	60	5	effects	effect	NOUN
dpc-2776	60	6	.	.	PUNCT
dpc-2776	61	1	patient	patient	ADJ
dpc-2776	61	2	characteristics	characteristic	NOUN
dpc-2776	61	3	n=180	n=180	PROPN
dpc-2776	61	4	age	age	NOUN
dpc-2776	61	5	mean	mean	VERB
dpc-2776	61	6	±	±	NOUN
dpc-2776	61	7	sd	sd	ADP
dpc-2776	61	8	median	median	PROPN
dpc-2776	61	9	(	(	PUNCT
dpc-2776	61	10	iqr	iqr	PROPN
dpc-2776	61	11	)	)	PUNCT
dpc-2776	61	12	20.3	20.3	NUM
dpc-2776	61	13	±	±	NUM
dpc-2776	61	14	5	5	NUM
dpc-2776	61	15	20	20	NUM
dpc-2776	61	16	(	(	PUNCT
dpc-2776	61	17	17	17	NUM
dpc-2776	61	18	–	–	SYM
dpc-2776	61	19	22	22	NUM
dpc-2776	61	20	)	)	PUNCT
dpc-2776	61	21	gender	gender	NOUN
dpc-2776	61	22	,	,	PUNCT
dpc-2776	61	23	n	n	CCONJ
dpc-2776	61	24	(	(	PUNCT
dpc-2776	61	25	%	%	INTJ
dpc-2776	61	26	)	)	PUNCT
dpc-2776	61	27	male	male	ADJ
dpc-2776	61	28	female	female	NOUN
dpc-2776	61	29	57	57	NUM
dpc-2776	61	30	(	(	PUNCT
dpc-2776	61	31	31.7	31.7	NUM
dpc-2776	61	32	)	)	PUNCT
dpc-2776	61	33	123	123	NUM
dpc-2776	61	34	(	(	PUNCT
dpc-2776	61	35	68.3	68.3	NUM
dpc-2776	61	36	)	)	PUNCT
dpc-2776	61	37	side	side	NOUN
dpc-2776	61	38	effects	effect	NOUN
dpc-2776	61	39	,	,	PUNCT
dpc-2776	61	40	n	n	CCONJ
dpc-2776	61	41	(	(	PUNCT
dpc-2776	61	42	%	%	INTJ
dpc-2776	61	43	)	)	PUNCT
dpc-2776	61	44	fatigue	fatigue	NOUN
dpc-2776	61	45	myalgia	myalgia	PROPN
dpc-2776	61	46	low	low	ADJ
dpc-2776	61	47	back	back	ADJ
dpc-2776	61	48	pain	pain	NOUN
dpc-2776	61	49	8	8	NUM
dpc-2776	61	50	(	(	PUNCT
dpc-2776	61	51	4.4	4.4	NUM
dpc-2776	61	52	)	)	PUNCT
dpc-2776	61	53	5	5	NUM
dpc-2776	61	54	(	(	PUNCT
dpc-2776	61	55	2.8	2.8	NUM
dpc-2776	61	56	)	)	PUNCT
dpc-2776	61	57	45	45	NUM
dpc-2776	61	58	(	(	PUNCT
dpc-2776	61	59	25	25	NUM
dpc-2776	61	60	)	)	PUNCT
dpc-2776	61	61	character	character	NOUN
dpc-2776	61	62	of	of	ADP
dpc-2776	61	63	low	low	ADJ
dpc-2776	61	64	back	back	ADJ
dpc-2776	61	65	pain	pain	NOUN
dpc-2776	61	66	,	,	PUNCT
dpc-2776	61	67	n	n	CCONJ
dpc-2776	61	68	(	(	PUNCT
dpc-2776	61	69	%	%	INTJ
dpc-2776	61	70	)	)	PUNCT
dpc-2776	61	71	inflammatory	inflammatory	ADJ
dpc-2776	61	72	mechanical	mechanical	ADJ
dpc-2776	61	73	4	4	NUM
dpc-2776	61	74	(	(	PUNCT
dpc-2776	61	75	2.2	2.2	NUM
dpc-2776	61	76	)	)	PUNCT
dpc-2776	61	77	41	41	NUM
dpc-2776	61	78	(	(	PUNCT
dpc-2776	61	79	22.8	22.8	NUM
dpc-2776	61	80	)	)	PUNCT
dpc-2776	61	81	treatment	treatment	NOUN
dpc-2776	61	82	duration	duration	NOUN
dpc-2776	61	83	(	(	PUNCT
dpc-2776	61	84	weeks	week	NOUN
dpc-2776	61	85	)	)	PUNCT
dpc-2776	61	86	mean	mean	VERB
dpc-2776	61	87	±	±	NUM
dpc-2776	61	88	sd	sd	ADP
dpc-2776	61	89	median	median	PROPN
dpc-2776	61	90	(	(	PUNCT
dpc-2776	61	91	iqr	iqr	PROPN
dpc-2776	61	92	)	)	PUNCT
dpc-2776	61	93	9.6	9.6	NUM
dpc-2776	61	94	±	±	NUM
dpc-2776	61	95	6,7	6,7	NUM
dpc-2776	61	96	8	8	NUM
dpc-2776	61	97	(	(	PUNCT
dpc-2776	61	98	4	4	NUM
dpc-2776	61	99	–	–	SYM
dpc-2776	61	100	12	12	NUM
dpc-2776	61	101	)	)	PUNCT
dpc-2776	61	102	isotretinoin	isotretinoin	PROPN
dpc-2776	61	103	naiveness	naiveness	NOUN
dpc-2776	61	104	,	,	PUNCT
dpc-2776	61	105	n	n	PROPN
dpc-2776	61	106	(	(	PUNCT
dpc-2776	61	107	%	%	INTJ
dpc-2776	61	108	)	)	PUNCT
dpc-2776	61	109	naive	naive	ADJ
dpc-2776	61	110	not	not	PART
dpc-2776	61	111	naive	naive	ADJ
dpc-2776	61	112	144	144	NUM
dpc-2776	61	113	(	(	PUNCT
dpc-2776	61	114	80	80	NUM
dpc-2776	61	115	)	)	PUNCT
dpc-2776	61	116	36	36	NUM
dpc-2776	61	117	(	(	PUNCT
dpc-2776	61	118	20	20	NUM
dpc-2776	61	119	)	)	PUNCT
dpc-2776	61	120	isotretinoin	isotretinoin	PROPN
dpc-2776	61	121	dosage	dosage	NOUN
dpc-2776	61	122	(	(	PUNCT
dpc-2776	61	123	mg	mg	PROPN
dpc-2776	61	124	/	/	SYM
dpc-2776	61	125	kg	kg	PROPN
dpc-2776	61	126	/	/	SYM
dpc-2776	61	127	day	day	NOUN
dpc-2776	61	128	)	)	PUNCT
dpc-2776	61	129	mean	mean	VERB
dpc-2776	61	130	±	±	NUM
dpc-2776	61	131	sd	sd	ADP
dpc-2776	61	132	median	median	PROPN
dpc-2776	61	133	(	(	PUNCT
dpc-2776	61	134	iqr	iqr	NOUN
dpc-2776	61	135	)	)	PUNCT
dpc-2776	61	136	0.582	0.582	NUM
dpc-2776	61	137	±	±	NUM
dpc-2776	61	138	0.18	0.18	NUM
dpc-2776	61	139	0.565	0.565	NUM
dpc-2776	61	140	(	(	PUNCT
dpc-2776	61	141	0.5	0.5	NUM
dpc-2776	61	142	–	–	PUNCT
dpc-2776	61	143	0.695	0.695	NUM
dpc-2776	61	144	)	)	PUNCT
dpc-2776	61	145	iqr	iqr	NOUN
dpc-2776	62	1	=	=	NOUN
dpc-2776	62	2	interquartile	interquartile	NOUN
dpc-2776	62	3	range	range	NOUN
dpc-2776	62	4	;	;	PUNCT
dpc-2776	62	5	sd	sd	NOUN
dpc-2776	62	6	=	=	SYM
dpc-2776	62	7	standard	standard	ADJ
dpc-2776	62	8	deviation	deviation	NOUN
dpc-2776	62	9	.	.	PUNCT
dpc-2776	63	1	table	table	NOUN
dpc-2776	63	2	2	2	NUM
dpc-2776	63	3	.	.	X
dpc-2776	63	4	relationship	relationship	NOUN
dpc-2776	63	5	of	of	ADP
dpc-2776	63	6	side	side	NOUN
dpc-2776	63	7	effects	effect	NOUN
dpc-2776	63	8	to	to	ADP
dpc-2776	63	9	patient	patient	ADJ
dpc-2776	63	10	characteristics	characteristic	NOUN
dpc-2776	63	11	.	.	PUNCT
dpc-2776	64	1	fatigue	fatigue	NOUN
dpc-2776	64	2	myalgia	myalgia	PROPN
dpc-2776	64	3	low	low	ADJ
dpc-2776	64	4	back	back	ADJ
dpc-2776	64	5	pain	pain	NOUN
dpc-2776	64	6	present	present	ADJ
dpc-2776	64	7	absent	absent	ADJ
dpc-2776	64	8	present	present	ADJ
dpc-2776	64	9	absent	absent	ADJ
dpc-2776	64	10	present	present	ADJ
dpc-2776	64	11	absent	absent	ADJ
dpc-2776	64	12	mean	mean	NOUN
dpc-2776	64	13	age	age	NOUN
dpc-2776	64	14	±,sd	±,sd	PUNCT
dpc-2776	64	15	median	median	ADJ
dpc-2776	64	16	(	(	PUNCT
dpc-2776	64	17	range	range	NOUN
dpc-2776	64	18	)	)	PUNCT
dpc-2776	64	19	in	in	ADP
dpc-2776	64	20	years	year	NOUN
dpc-2776	64	21	19.8	19.8	NUM
dpc-2776	64	22	±	±	NUM
dpc-2776	64	23	2	2	NUM
dpc-2776	64	24	20	20	NUM
dpc-2776	64	25	(	(	PUNCT
dpc-2776	64	26	18	18	NUM
dpc-2776	64	27	-21	-21	NOUN
dpc-2776	64	28	)	)	PUNCT
dpc-2776	64	29	20.3	20.3	NUM
dpc-2776	64	30	±	±	NUM
dpc-2776	64	31	5.1	5.1	NUM
dpc-2776	64	32	20	20	NUM
dpc-2776	64	33	(	(	PUNCT
dpc-2776	64	34	17	17	NUM
dpc-2776	64	35	–	–	SYM
dpc-2776	64	36	22	22	NUM
dpc-2776	64	37	)	)	PUNCT
dpc-2776	64	38	21.6	21.6	NUM
dpc-2776	64	39	±	±	NUM
dpc-2776	64	40	2	2	NUM
dpc-2776	64	41	21	21	NUM
dpc-2776	64	42	(	(	PUNCT
dpc-2776	64	43	20	20	NUM
dpc-2776	64	44	–	–	PUNCT
dpc-2776	64	45	23,5	23,5	NUM
dpc-2776	64	46	)	)	PUNCT
dpc-2776	64	47	20.3	20.3	NUM
dpc-2776	64	48	±	±	NUM
dpc-2776	64	49	5.1	5.1	NUM
dpc-2776	64	50	20	20	NUM
dpc-2776	64	51	(	(	PUNCT
dpc-2776	64	52	17	17	NUM
dpc-2776	64	53	–	–	SYM
dpc-2776	64	54	22	22	NUM
dpc-2776	64	55	)	)	PUNCT
dpc-2776	64	56	19.3	19.3	NUM
dpc-2776	64	57	±	±	NUM
dpc-2776	64	58	4.2	4.2	NUM
dpc-2776	64	59	19	19	NUM
dpc-2776	64	60	(	(	PUNCT
dpc-2776	64	61	16	16	NUM
dpc-2776	64	62	–	–	SYM
dpc-2776	64	63	21	21	NUM
dpc-2776	64	64	)	)	PUNCT
dpc-2776	64	65	20.6	20.6	NUM
dpc-2776	64	66	±	±	NUM
dpc-2776	64	67	5.3	5.3	NUM
dpc-2776	64	68	20	20	NUM
dpc-2776	64	69	(	(	PUNCT
dpc-2776	64	70	17	17	NUM
dpc-2776	64	71	–	–	SYM
dpc-2776	64	72	22	22	NUM
dpc-2776	64	73	)	)	PUNCT
dpc-2776	64	74	p	p	NOUN
dpc-2776	64	75	0.906a	0.906a	NUM
dpc-2776	64	76	0.162	0.162	NUM
dpc-2776	64	77	a	a	DET
dpc-2776	64	78	0.1	0.1	NUM
dpc-2776	64	79	a	a	DET
dpc-2776	64	80	gender	gender	NOUN
dpc-2776	64	81	male	male	ADJ
dpc-2776	64	82	female	female	ADJ
dpc-2776	64	83	2	2	NUM
dpc-2776	64	84	(	(	PUNCT
dpc-2776	64	85	25	25	NUM
dpc-2776	64	86	)	)	PUNCT
dpc-2776	64	87	6	6	NUM
dpc-2776	64	88	(	(	PUNCT
dpc-2776	64	89	75	75	NUM
dpc-2776	64	90	)	)	PUNCT
dpc-2776	64	91	55	55	NUM
dpc-2776	64	92	(	(	PUNCT
dpc-2776	64	93	32	32	NUM
dpc-2776	64	94	)	)	SYM
dpc-2776	64	95	117	117	NUM
dpc-2776	64	96	(	(	PUNCT
dpc-2776	64	97	68	68	NUM
dpc-2776	64	98	)	)	PUNCT
dpc-2776	64	99	0	0	NUM
dpc-2776	65	1	(	(	PUNCT
dpc-2776	65	2	0	0	NUM
dpc-2776	65	3	)	)	SYM
dpc-2776	65	4	5	5	NUM
dpc-2776	65	5	(	(	PUNCT
dpc-2776	65	6	100	100	NUM
dpc-2776	65	7	)	)	PUNCT
dpc-2776	65	8	57	57	NUM
dpc-2776	65	9	(	(	PUNCT
dpc-2776	65	10	32.6	32.6	NUM
dpc-2776	65	11	)	)	PUNCT
dpc-2776	65	12	118	118	NUM
dpc-2776	65	13	(	(	PUNCT
dpc-2776	65	14	67.4	67.4	NUM
dpc-2776	65	15	)	)	PUNCT
dpc-2776	65	16	14	14	NUM
dpc-2776	65	17	(	(	PUNCT
dpc-2776	65	18	31.1	31.1	NUM
dpc-2776	65	19	)	)	PUNCT
dpc-2776	65	20	31	31	NUM
dpc-2776	65	21	(	(	PUNCT
dpc-2776	65	22	68.9	68.9	NUM
dpc-2776	65	23	)	)	PUNCT
dpc-2776	65	24	43	43	NUM
dpc-2776	65	25	(	(	PUNCT
dpc-2776	65	26	31.9	31.9	NUM
dpc-2776	65	27	)	)	PUNCT
dpc-2776	65	28	92	92	NUM
dpc-2776	65	29	(	(	PUNCT
dpc-2776	65	30	68.1	68.1	NUM
dpc-2776	65	31	)	)	PUNCT
dpc-2776	65	32	p	p	NOUN
dpc-2776	65	33	0.678	0.678	NUM
dpc-2776	65	34	b	b	NUM
dpc-2776	65	35	0.181	0.181	NUM
dpc-2776	65	36	c	c	NOUN
dpc-2776	65	37	0.926	0.926	NUM
dpc-2776	65	38	b	b	NOUN
dpc-2776	65	39	isotretinoin	isotretinoin	ADJ
dpc-2776	65	40	dosage	dosage	NOUN
dpc-2776	65	41	(	(	PUNCT
dpc-2776	65	42	mg/	mg/	PROPN
dpc-2776	65	43	kg	kg	PROPN
dpc-2776	65	44	/	/	SYM
dpc-2776	65	45	day	day	NOUN
dpc-2776	65	46	)	)	PUNCT
dpc-2776	65	47	0.625	0.625	NUM
dpc-2776	65	48	±	±	NUM
dpc-2776	65	49	0.2	0.2	NUM
dpc-2776	65	50	0.58	0.58	NUM
dpc-2776	65	51	(	(	PUNCT
dpc-2776	65	52	0.46	0.46	NUM
dpc-2776	65	53	–	–	PUNCT
dpc-2776	65	54	0.73	0.73	NUM
dpc-2776	65	55	)	)	PUNCT
dpc-2776	65	56	0.58	0.58	NUM
dpc-2776	65	57	±	±	NOUN
dpc-2776	65	58	0.2	0.2	NUM
dpc-2776	65	59	0.57	0.57	NUM
dpc-2776	65	60	(	(	PUNCT
dpc-2776	65	61	0.5	0.5	NUM
dpc-2776	65	62	–	–	SYM
dpc-2776	65	63	0.68	0.68	NUM
dpc-2776	65	64	)	)	PUNCT
dpc-2776	65	65	0.582	0.582	NUM
dpc-2776	65	66	±	±	NUM
dpc-2776	65	67	0.2	0.2	NUM
dpc-2776	65	68	0.6	0.6	NUM
dpc-2776	65	69	(	(	PUNCT
dpc-2776	65	70	0.4	0.4	NUM
dpc-2776	65	71	–	–	SYM
dpc-2776	65	72	0.76	0.76	NUM
dpc-2776	65	73	)	)	PUNCT
dpc-2776	65	74	0.582	0.582	NUM
dpc-2776	65	75	±	±	NUM
dpc-2776	65	76	0.2	0.2	NUM
dpc-2776	65	77	0.56	0.56	NUM
dpc-2776	65	78	(	(	PUNCT
dpc-2776	65	79	0.5	0.5	NUM
dpc-2776	65	80	–	–	SYM
dpc-2776	65	81	0.68	0.68	NUM
dpc-2776	65	82	)	)	PUNCT
dpc-2776	65	83	0.599	0.599	NUM
dpc-2776	65	84	±	±	NUM
dpc-2776	65	85	0.2	0.2	NUM
dpc-2776	65	86	0.6	0.6	NUM
dpc-2776	65	87	(	(	PUNCT
dpc-2776	65	88	0.5	0.5	NUM
dpc-2776	65	89	–	–	PUNCT
dpc-2776	65	90	0.69	0.69	NUM
dpc-2776	65	91	)	)	PUNCT
dpc-2776	65	92	0.576	0.576	NUM
dpc-2776	65	93	±	±	NUM
dpc-2776	65	94	0.2	0.2	NUM
dpc-2776	65	95	0.5	0.5	NUM
dpc-2776	65	96	(	(	PUNCT
dpc-2776	65	97	0.44	0.44	NUM
dpc-2776	65	98	–	–	PUNCT
dpc-2776	65	99	0.7	0.7	NUM
dpc-2776	65	100	)	)	PUNCT
dpc-2776	65	101	p	p	NOUN
dpc-2776	65	102	0.608	0.608	NUM
dpc-2776	65	103	a	a	DET
dpc-2776	65	104	0.951	0.951	NUM
dpc-2776	65	105	a	a	DET
dpc-2776	65	106	0.23	0.23	NUM
dpc-2776	65	107	a	a	DET
dpc-2776	65	108	treatment	treatment	NOUN
dpc-2776	65	109	duration	duration	NOUN
dpc-2776	65	110	(	(	PUNCT
dpc-2776	65	111	weeks	week	NOUN
dpc-2776	65	112	)	)	PUNCT
dpc-2776	66	1	9.9	9.9	NUM
dpc-2776	66	2	±8.7	±8.7	NOUN
dpc-2776	66	3	4	4	NUM
dpc-2776	66	4	(	(	PUNCT
dpc-2776	66	5	4	4	NUM
dpc-2776	66	6	–	–	SYM
dpc-2776	66	7	19	19	NUM
dpc-2776	66	8	)	)	PUNCT
dpc-2776	66	9	9.6	9.6	NUM
dpc-2776	66	10	±	±	NUM
dpc-2776	66	11	6.7	6.7	NUM
dpc-2776	66	12	8	8	NUM
dpc-2776	66	13	(	(	PUNCT
dpc-2776	66	14	4	4	NUM
dpc-2776	66	15	–	–	SYM
dpc-2776	66	16	12	12	NUM
dpc-2776	66	17	)	)	PUNCT
dpc-2776	66	18	13.6	13.6	NUM
dpc-2776	66	19	±	±	NUM
dpc-2776	66	20	9.2	9.2	NUM
dpc-2776	66	21	16	16	NUM
dpc-2776	66	22	(	(	PUNCT
dpc-2776	66	23	4	4	NUM
dpc-2776	66	24	–	–	SYM
dpc-2776	66	25	22	22	NUM
dpc-2776	66	26	)	)	PUNCT
dpc-2776	66	27	9.5	9.5	NUM
dpc-2776	66	28	±	±	NUM
dpc-2776	66	29	6.7	6.7	NUM
dpc-2776	66	30	8	8	NUM
dpc-2776	66	31	(	(	PUNCT
dpc-2776	66	32	4	4	NUM
dpc-2776	66	33	–	–	SYM
dpc-2776	66	34	12	12	NUM
dpc-2776	66	35	)	)	PUNCT
dpc-2776	66	36	8.9	8.9	NUM
dpc-2776	66	37	±	±	NUM
dpc-2776	66	38	6.7	6.7	NUM
dpc-2776	66	39	8	8	NUM
dpc-2776	66	40	(	(	PUNCT
dpc-2776	66	41	4	4	NUM
dpc-2776	66	42	–	–	SYM
dpc-2776	66	43	12	12	NUM
dpc-2776	66	44	)	)	PUNCT
dpc-2776	66	45	9.8	9.8	NUM
dpc-2776	66	46	±	±	NUM
dpc-2776	66	47	6.8	6.8	NUM
dpc-2776	66	48	8	8	NUM
dpc-2776	66	49	(	(	PUNCT
dpc-2776	66	50	4	4	NUM
dpc-2776	66	51	–	–	SYM
dpc-2776	66	52	12	12	NUM
dpc-2776	66	53	)	)	PUNCT
dpc-2776	66	54	p	p	NOUN
dpc-2776	66	55	0.583	0.583	NUM
dpc-2776	66	56	a	a	DET
dpc-2776	66	57	0.324	0.324	NUM
dpc-2776	66	58	a	a	DET
dpc-2776	66	59	0.391	0.391	NUM
dpc-2776	66	60	a	a	DET
dpc-2776	66	61	isotretinoin	isotretinoin	NOUN
dpc-2776	66	62	-	-	PUNCT
dpc-2776	66	63	naiveness	naiveness	NOUN
dpc-2776	66	64	naive	naive	ADJ
dpc-2776	66	65	not	not	PART
dpc-2776	66	66	naive	naive	ADJ
dpc-2776	66	67	7	7	NUM
dpc-2776	66	68	(	(	PUNCT
dpc-2776	66	69	87.5	87.5	NUM
dpc-2776	66	70	)	)	PUNCT
dpc-2776	66	71	1	1	NUM
dpc-2776	66	72	(	(	PUNCT
dpc-2776	66	73	12.5	12.5	NUM
dpc-2776	66	74	)	)	SYM
dpc-2776	66	75	137	137	NUM
dpc-2776	66	76	(	(	PUNCT
dpc-2776	66	77	79.7	79.7	NUM
dpc-2776	66	78	)	)	PUNCT
dpc-2776	66	79	35	35	NUM
dpc-2776	66	80	(	(	PUNCT
dpc-2776	66	81	20.3	20.3	NUM
dpc-2776	66	82	)	)	SYM
dpc-2776	66	83	5	5	NUM
dpc-2776	66	84	(	(	PUNCT
dpc-2776	66	85	100	100	NUM
dpc-2776	66	86	)	)	PUNCT
dpc-2776	66	87	0	0	NUM
dpc-2776	67	1	(	(	PUNCT
dpc-2776	67	2	0	0	NUM
dpc-2776	67	3	)	)	PUNCT
dpc-2776	67	4	139	139	NUM
dpc-2776	67	5	(	(	PUNCT
dpc-2776	67	6	79.4	79.4	NUM
dpc-2776	67	7	)	)	PUNCT
dpc-2776	67	8	36	36	NUM
dpc-2776	67	9	(	(	PUNCT
dpc-2776	67	10	20.6	20.6	NUM
dpc-2776	67	11	)	)	PUNCT
dpc-2776	67	12	38	38	NUM
dpc-2776	67	13	(	(	PUNCT
dpc-2776	67	14	84.4	84.4	NUM
dpc-2776	67	15	)	)	PUNCT
dpc-2776	67	16	7	7	NUM
dpc-2776	67	17	(	(	PUNCT
dpc-2776	67	18	15.6	15.6	NUM
dpc-2776	67	19	)	)	PUNCT
dpc-2776	67	20	106	106	NUM
dpc-2776	67	21	(	(	PUNCT
dpc-2776	67	22	78.5	78.5	NUM
dpc-2776	67	23	)	)	PUNCT
dpc-2776	67	24	29	29	NUM
dpc-2776	67	25	(	(	PUNCT
dpc-2776	67	26	21.5	21.5	NUM
dpc-2776	67	27	)	)	PUNCT
dpc-2776	68	1	p	p	NOUN
dpc-2776	68	2	1	1	NUM
dpc-2776	68	3	c	c	NOUN
dpc-2776	68	4	0,585	0,585	NUM
dpc-2776	68	5	c	c	NOUN
dpc-2776	68	6	0,389	0,389	NUM
dpc-2776	68	7	b	b	NOUN
dpc-2776	68	8	a	a	DET
dpc-2776	68	9	mann	mann	PROPN
dpc-2776	68	10	whitney	whitney	PROPN
dpc-2776	68	11	u	u	PROPN
dpc-2776	68	12	test	test	NOUN
dpc-2776	68	13	;	;	PUNCT
dpc-2776	68	14	2pearson	2pearson	NUM
dpc-2776	68	15	chi	chi	ADJ
dpc-2776	68	16	-	-	PUNCT
dpc-2776	68	17	squared	square	VERB
dpc-2776	68	18	test	test	NOUN
dpc-2776	68	19	;	;	PUNCT
dpc-2776	68	20	c	c	PROPN
dpc-2776	68	21	fisher	fisher	PROPN
dpc-2776	68	22	exact	exact	PROPN
dpc-2776	68	23	test	test	NOUN
dpc-2776	68	24	.	.	PUNCT
dpc-2776	69	1	conclusions	conclusion	NOUN
dpc-2776	69	2	systemic	systemic	ADJ
dpc-2776	69	3	isotretinoin	isotretinoin	PROPN
dpc-2776	69	4	therapy	therapy	NOUN
dpc-2776	69	5	is	be	AUX
dpc-2776	69	6	known	know	VERB
dpc-2776	69	7	to	to	PART
dpc-2776	69	8	have	have	VERB
dpc-2776	69	9	side	side	ADJ
dpc-2776	69	10	effects	effect	NOUN
dpc-2776	69	11	in	in	ADP
dpc-2776	69	12	many	many	ADJ
dpc-2776	69	13	organ	organ	NOUN
dpc-2776	69	14	systems	system	NOUN
dpc-2776	69	15	,	,	PUNCT
dpc-2776	69	16	including	include	VERB
dpc-2776	69	17	the	the	DET
dpc-2776	69	18	musculoskeletal	musculoskeletal	ADJ
dpc-2776	69	19	system	system	NOUN
dpc-2776	69	20	4	4	NUM
dpc-2776	69	21	original	original	ADJ
dpc-2776	69	22	article	article	NOUN
dpc-2776	69	23	|	|	ADV
dpc-2776	69	24	dermatol	dermatol	ADJ
dpc-2776	69	25	pract	pract	NOUN
dpc-2776	69	26	concept	concept	NOUN
dpc-2776	69	27	.	.	PUNCT
dpc-2776	70	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	70	2	average	average	ADJ
dpc-2776	70	3	doses	dose	NOUN
dpc-2776	70	4	prescribed	prescribe	VERB
dpc-2776	70	5	in	in	ADP
dpc-2776	70	6	the	the	DET
dpc-2776	70	7	literature	literature	NOUN
dpc-2776	70	8	:	:	PUNCT
dpc-2776	70	9	0.6	0.6	NUM
dpc-2776	70	10	mg	mg	PROPN
dpc-2776	70	11	/	/	SYM
dpc-2776	70	12	kg	kg	PROPN
dpc-2776	70	13	/	/	SYM
dpc-2776	70	14	day	day	NOUN
dpc-2776	70	15	,	,	PUNCT
dpc-2776	70	16	0.55	0.55	NUM
dpc-2776	70	17	mg	mg	PROPN
dpc-2776	70	18	/	/	SYM
dpc-2776	70	19	kg	kg	NOUN
dpc-2776	70	20	/	/	SYM
dpc-2776	70	21	day	day	NOUN
dpc-2776	70	22	and	and	CCONJ
dpc-2776	70	23	0.53	0.53	NUM
dpc-2776	70	24	mg	mg	PROPN
dpc-2776	70	25	/	/	SYM
dpc-2776	70	26	kg	kg	PROPN
dpc-2776	70	27	/	/	SYM
dpc-2776	70	28	day[4,11,12	day[4,11,12	PROPN
dpc-2776	70	29	]	]	PUNCT
dpc-2776	70	30	.	.	PUNCT
dpc-2776	71	1	there	there	PRON
dpc-2776	71	2	was	be	VERB
dpc-2776	71	3	no	no	DET
dpc-2776	71	4	relationship	relationship	NOUN
dpc-2776	71	5	between	between	ADP
dpc-2776	71	6	the	the	DET
dpc-2776	71	7	daily	daily	ADJ
dpc-2776	71	8	dose	dose	NOUN
dpc-2776	71	9	of	of	ADP
dpc-2776	71	10	systemic	systemic	ADJ
dpc-2776	71	11	isotretinoin	isotretinoin	PROPN
dpc-2776	71	12	treatment	treatment	NOUN
dpc-2776	71	13	and	and	CCONJ
dpc-2776	71	14	the	the	DET
dpc-2776	71	15	prevalence	prevalence	NOUN
dpc-2776	71	16	of	of	ADP
dpc-2776	71	17	the	the	DET
dpc-2776	71	18	side	side	NOUN
dpc-2776	71	19	effects	effect	NOUN
dpc-2776	71	20	.	.	PUNCT
dpc-2776	72	1	in	in	ADP
dpc-2776	72	2	alignment	alignment	NOUN
dpc-2776	72	3	with	with	ADP
dpc-2776	72	4	this	this	DET
dpc-2776	72	5	result	result	NOUN
dpc-2776	72	6	,	,	PUNCT
dpc-2776	72	7	karaosmanoğlu	karaosmanoğlu	PROPN
dpc-2776	72	8	and	and	CCONJ
dpc-2776	72	9	mülkoğlu	mülkoğlu	PROPN
dpc-2776	72	10	also	also	ADV
dpc-2776	72	11	concluded	conclude	VERB
dpc-2776	72	12	that	that	SCONJ
dpc-2776	72	13	there	there	PRON
dpc-2776	72	14	is	be	VERB
dpc-2776	72	15	no	no	DET
dpc-2776	72	16	correlation	correlation	NOUN
dpc-2776	72	17	between	between	ADP
dpc-2776	72	18	the	the	DET
dpc-2776	72	19	cumulative	cumulative	ADJ
dpc-2776	72	20	dosage	dosage	NOUN
dpc-2776	72	21	of	of	ADP
dpc-2776	72	22	isotretinoin	isotretinoin	PROPN
dpc-2776	72	23	and	and	CCONJ
dpc-2776	72	24	the	the	DET
dpc-2776	72	25	severity	severity	NOUN
dpc-2776	72	26	of	of	ADP
dpc-2776	72	27	low	low	ADJ
dpc-2776	72	28	back	back	ADJ
dpc-2776	72	29	pain	pain	NOUN
dpc-2776	73	1	[	[	X
dpc-2776	73	2	8	8	NUM
dpc-2776	73	3	]	]	PUNCT
dpc-2776	73	4	.	.	PUNCT
dpc-2776	74	1	previously	previously	ADV
dpc-2776	74	2	in	in	ADP
dpc-2776	74	3	the	the	DET
dpc-2776	74	4	literature	literature	NOUN
dpc-2776	74	5	,	,	PUNCT
dpc-2776	74	6	acar	acar	VERB
dpc-2776	74	7	et	et	NOUN
dpc-2776	74	8	al	al	PROPN
dpc-2776	74	9	reported	report	VERB
dpc-2776	74	10	that	that	SCONJ
dpc-2776	74	11	low	low	ADJ
dpc-2776	74	12	back	back	ADJ
dpc-2776	74	13	pain	pain	NOUN
dpc-2776	74	14	was	be	AUX
dpc-2776	74	15	more	more	ADV
dpc-2776	74	16	common	common	ADJ
dpc-2776	74	17	in	in	ADP
dpc-2776	74	18	male	male	ADJ
dpc-2776	74	19	patients	patient	NOUN
dpc-2776	74	20	and	and	CCONJ
dpc-2776	74	21	pain	pain	NOUN
dpc-2776	74	22	severity	severity	NOUN
dpc-2776	74	23	increased	increase	VERB
dpc-2776	74	24	with	with	ADP
dpc-2776	74	25	increasing	increase	VERB
dpc-2776	74	26	age	age	NOUN
dpc-2776	74	27	[	[	X
dpc-2776	74	28	4	4	NUM
dpc-2776	74	29	]	]	PUNCT
dpc-2776	74	30	.	.	PUNCT
dpc-2776	75	1	in	in	ADP
dpc-2776	75	2	contrast	contrast	NOUN
dpc-2776	75	3	,	,	PUNCT
dpc-2776	75	4	this	this	DET
dpc-2776	75	5	study	study	NOUN
dpc-2776	75	6	revealed	reveal	VERB
dpc-2776	75	7	that	that	SCONJ
dpc-2776	75	8	the	the	DET
dpc-2776	75	9	side	side	NOUN
dpc-2776	75	10	effects	effect	NOUN
dpc-2776	75	11	of	of	ADP
dpc-2776	75	12	systemic	systemic	ADJ
dpc-2776	75	13	isotretinoin	isotretinoin	PROPN
dpc-2776	75	14	treatment	treatment	NOUN
dpc-2776	75	15	are	be	AUX
dpc-2776	75	16	independent	independent	ADJ
dpc-2776	75	17	of	of	ADP
dpc-2776	75	18	age	age	NOUN
dpc-2776	75	19	and	and	CCONJ
dpc-2776	75	20	gender	gender	NOUN
dpc-2776	75	21	.	.	PUNCT
dpc-2776	76	1	our	our	PRON
dpc-2776	76	2	study	study	NOUN
dpc-2776	76	3	also	also	ADV
dpc-2776	76	4	revealed	reveal	VERB
dpc-2776	76	5	that	that	SCONJ
dpc-2776	76	6	side	side	NOUN
dpc-2776	76	7	effects	effect	NOUN
dpc-2776	76	8	of	of	ADP
dpc-2776	76	9	systemic	systemic	ADJ
dpc-2776	76	10	isotretinoin	isotretinoin	PROPN
dpc-2776	76	11	are	be	AUX
dpc-2776	76	12	independent	independent	ADJ
dpc-2776	76	13	of	of	ADP
dpc-2776	76	14	the	the	DET
dpc-2776	76	15	treatment	treatment	NOUN
dpc-2776	76	16	duration	duration	NOUN
dpc-2776	76	17	and	and	CCONJ
dpc-2776	76	18	isotretinoin	isotretinoin	PROPN
dpc-2776	76	19	naiveness	naiveness	NOUN
dpc-2776	76	20	of	of	ADP
dpc-2776	76	21	the	the	DET
dpc-2776	76	22	patient	patient	NOUN
dpc-2776	76	23	.	.	PUNCT
dpc-2776	77	1	although	although	SCONJ
dpc-2776	77	2	systemic	systemic	ADJ
dpc-2776	77	3	isotretinoin	isotretinoin	PROPN
dpc-2776	77	4	treatment	treatment	NOUN
dpc-2776	77	5	is	be	AUX
dpc-2776	77	6	the	the	DET
dpc-2776	77	7	most	most	ADV
dpc-2776	77	8	effective	effective	ADJ
dpc-2776	77	9	treatment	treatment	NOUN
dpc-2776	77	10	modality	modality	NOUN
dpc-2776	77	11	for	for	ADP
dpc-2776	77	12	acne	acne	NOUN
dpc-2776	77	13	vulgaris	vulgaris	NOUN
dpc-2776	77	14	,	,	PUNCT
dpc-2776	77	15	both	both	DET
dpc-2776	77	16	patients	patient	NOUN
dpc-2776	77	17	and	and	CCONJ
dpc-2776	77	18	prescribing	prescribe	VERB
dpc-2776	77	19	physicians	physician	NOUN
dpc-2776	77	20	express	express	VERB
dpc-2776	77	21	fear	fear	NOUN
dpc-2776	77	22	about	about	ADP
dpc-2776	77	23	the	the	DET
dpc-2776	77	24	side	side	NOUN
dpc-2776	77	25	effects	effect	NOUN
dpc-2776	77	26	 	 	SPACE
dpc-2776	78	1	[	[	X
dpc-2776	78	2	13	13	NUM
dpc-2776	78	3	]	]	PUNCT
dpc-2776	78	4	.	.	PUNCT
dpc-2776	79	1	compared	compare	VERB
dpc-2776	79	2	to	to	ADP
dpc-2776	79	3	the	the	DET
dpc-2776	79	4	previous	previous	ADJ
dpc-2776	79	5	literature	literature	NOUN
dpc-2776	79	6	,	,	PUNCT
dpc-2776	79	7	we	we	PRON
dpc-2776	79	8	report	report	VERB
dpc-2776	79	9	a	a	DET
dpc-2776	79	10	lower	low	ADJ
dpc-2776	79	11	prevalence	prevalence	NOUN
dpc-2776	79	12	of	of	ADP
dpc-2776	79	13	fatigue	fatigue	NOUN
dpc-2776	79	14	and	and	CCONJ
dpc-2776	79	15	musculoskeletal	musculoskeletal	ADJ
dpc-2776	79	16	side	side	NOUN
dpc-2776	79	17	effects	effect	NOUN
dpc-2776	79	18	(	(	PUNCT
dpc-2776	79	19	namely	namely	ADV
dpc-2776	79	20	myalgia	myalgia	NOUN
dpc-2776	79	21	and	and	CCONJ
dpc-2776	79	22	low	low	ADJ
dpc-2776	79	23	back	back	ADJ
dpc-2776	79	24	pain	pain	NOUN
dpc-2776	79	25	)	)	PUNCT
dpc-2776	79	26	and	and	CCONJ
dpc-2776	79	27	no	no	DET
dpc-2776	79	28	case	case	NOUN
dpc-2776	79	29	of	of	ADP
dpc-2776	79	30	sacroiliitis	sacroiliitis	NOUN
dpc-2776	79	31	in	in	ADP
dpc-2776	79	32	our	our	PRON
dpc-2776	79	33	patient	patient	ADJ
dpc-2776	79	34	population	population	NOUN
dpc-2776	79	35	,	,	PUNCT
dpc-2776	79	36	which	which	PRON
dpc-2776	79	37	supports	support	VERB
dpc-2776	79	38	the	the	DET
dpc-2776	79	39	use	use	NOUN
dpc-2776	79	40	of	of	ADP
dpc-2776	79	41	systemic	systemic	ADJ
dpc-2776	79	42	isotretinoin	isotretinoin	PROPN
dpc-2776	79	43	in	in	ADP
dpc-2776	79	44	indicated	indicate	VERB
dpc-2776	79	45	cases	case	NOUN
dpc-2776	79	46	of	of	ADP
dpc-2776	79	47	acne	acne	NOUN
dpc-2776	79	48	vulgaris	vulgaris	NOUN
dpc-2776	79	49	.	.	PUNCT
dpc-2776	80	1	furthermore	furthermore	ADV
dpc-2776	80	2	,	,	PUNCT
dpc-2776	80	3	we	we	PRON
dpc-2776	80	4	also	also	ADV
dpc-2776	80	5	report	report	VERB
dpc-2776	80	6	that	that	SCONJ
dpc-2776	80	7	side	side	NOUN
dpc-2776	80	8	effects	effect	NOUN
dpc-2776	80	9	of	of	ADP
dpc-2776	80	10	isotretinoin	isotretinoin	PROPN
dpc-2776	80	11	treatment	treatment	NOUN
dpc-2776	80	12	are	be	AUX
dpc-2776	80	13	independent	independent	ADJ
dpc-2776	80	14	of	of	ADP
dpc-2776	80	15	age	age	NOUN
dpc-2776	80	16	,	,	PUNCT
dpc-2776	80	17	gender	gender	NOUN
dpc-2776	80	18	,	,	PUNCT
dpc-2776	80	19	daily	daily	ADJ
dpc-2776	80	20	isotretinoin	isotretinoin	PROPN
dpc-2776	80	21	dose	dose	PROPN
dpc-2776	80	22	,	,	PUNCT
dpc-2776	80	23	treatment	treatment	NOUN
dpc-2776	80	24	duration	duration	NOUN
dpc-2776	80	25	and	and	CCONJ
dpc-2776	80	26	isotretinoin	isotretinoin	PROPN
dpc-2776	80	27	naiveness	naiveness	NOUN
dpc-2776	80	28	of	of	ADP
dpc-2776	80	29	the	the	DET
dpc-2776	80	30	patient	patient	NOUN
dpc-2776	80	31	.	.	PUNCT
dpc-2776	81	1	fatigue	fatigue	NOUN
dpc-2776	81	2	,	,	PUNCT
dpc-2776	81	3	myalgia	myalgia	NOUN
dpc-2776	81	4	and	and	CCONJ
dpc-2776	81	5	low	low	ADJ
dpc-2776	82	1	back	back	ADJ
dpc-2776	82	2	pain	pain	NOUN
dpc-2776	82	3	can	can	AUX
dpc-2776	82	4	be	be	AUX
dpc-2776	82	5	observed	observe	VERB
dpc-2776	82	6	during	during	ADP
dpc-2776	82	7	systemic	systemic	ADJ
dpc-2776	82	8	isotretinoin	isotretinoin	PROPN
dpc-2776	82	9	treatment	treatment	NOUN
dpc-2776	82	10	.	.	PUNCT
dpc-2776	83	1	these	these	DET
dpc-2776	83	2	side	side	NOUN
dpc-2776	83	3	effects	effect	NOUN
dpc-2776	83	4	are	be	AUX
dpc-2776	83	5	independent	independent	ADJ
dpc-2776	83	6	of	of	ADP
dpc-2776	83	7	the	the	DET
dpc-2776	83	8	patient	patient	ADJ
dpc-2776	83	9	age	age	NOUN
dpc-2776	83	10	,	,	PUNCT
dpc-2776	83	11	gender	gender	NOUN
dpc-2776	83	12	,	,	PUNCT
dpc-2776	83	13	daily	daily	ADJ
dpc-2776	83	14	systemic	systemic	ADJ
dpc-2776	83	15	isotretinoin	isotretinoin	PROPN
dpc-2776	83	16	dosage	dosage	NOUN
dpc-2776	83	17	,	,	PUNCT
dpc-2776	83	18	treatment	treatment	NOUN
dpc-2776	83	19	duration	duration	NOUN
dpc-2776	83	20	and	and	CCONJ
dpc-2776	83	21	isotretinoin	isotretinoin	NOUN
dpc-2776	83	22	-	-	PUNCT
dpc-2776	83	23	naiveness	naiveness	NOUN
dpc-2776	83	24	of	of	ADP
dpc-2776	83	25	the	the	DET
dpc-2776	83	26	patient	patient	NOUN
dpc-2776	83	27	.	.	PUNCT
dpc-2776	84	1	the	the	DET
dpc-2776	84	2	side	side	NOUN
dpc-2776	84	3	effects	effect	NOUN
dpc-2776	84	4	are	be	AUX
dpc-2776	84	5	not	not	PART
dpc-2776	84	6	that	that	ADV
dpc-2776	84	7	common	common	ADJ
dpc-2776	84	8	;	;	PUNCT
dpc-2776	84	9	thus	thus	ADV
dpc-2776	84	10	,	,	PUNCT
dpc-2776	84	11	patients	patient	NOUN
dpc-2776	84	12	and	and	CCONJ
dpc-2776	84	13	physicians	physician	NOUN
dpc-2776	84	14	should	should	AUX
dpc-2776	84	15	not	not	PART
dpc-2776	84	16	hesitate	hesitate	VERB
dpc-2776	84	17	to	to	PART
dpc-2776	84	18	use	use	VERB
dpc-2776	84	19	systemic	systemic	ADJ
dpc-2776	84	20	isotretinoin	isotretinoin	NOUN
dpc-2776	84	21	in	in	ADP
dpc-2776	84	22	indicated	indicate	VERB
dpc-2776	84	23	cases	case	NOUN
dpc-2776	84	24	.	.	PUNCT
dpc-2776	85	1	[	[	X
dpc-2776	85	2	6,7	6,7	NUM
dpc-2776	85	3	]	]	PUNCT
dpc-2776	85	4	.	.	PUNCT
dpc-2776	86	1	low	low	ADJ
dpc-2776	86	2	back	back	ADJ
dpc-2776	86	3	pain	pain	NOUN
dpc-2776	86	4	has	have	AUX
dpc-2776	86	5	been	be	AUX
dpc-2776	86	6	reported	report	VERB
dpc-2776	86	7	to	to	PART
dpc-2776	86	8	be	be	AUX
dpc-2776	86	9	a	a	DET
dpc-2776	86	10	common	common	ADJ
dpc-2776	86	11	side	side	NOUN
dpc-2776	86	12	effect	effect	NOUN
dpc-2776	86	13	of	of	ADP
dpc-2776	86	14	systemic	systemic	ADJ
dpc-2776	86	15	isotretinoin	isotretinoin	PROPN
dpc-2776	86	16	therapy	therapy	NOUN
dpc-2776	86	17	in	in	ADP
dpc-2776	86	18	the	the	DET
dpc-2776	86	19	literature	literature	NOUN
dpc-2776	86	20	[	[	X
dpc-2776	86	21	5,8	5,8	NUM
dpc-2776	86	22	]	]	X
dpc-2776	86	23	.	.	PUNCT
dpc-2776	87	1	low	low	ADJ
dpc-2776	87	2	back	back	ADJ
dpc-2776	87	3	pain	pain	NOUN
dpc-2776	87	4	can	can	AUX
dpc-2776	87	5	be	be	AUX
dpc-2776	87	6	categorized	categorize	VERB
dpc-2776	87	7	into	into	ADP
dpc-2776	87	8	two	two	NUM
dpc-2776	87	9	groups	group	NOUN
dpc-2776	87	10	:	:	PUNCT
dpc-2776	87	11	inflammatory	inflammatory	ADJ
dpc-2776	87	12	,	,	PUNCT
dpc-2776	87	13	and	and	CCONJ
dpc-2776	87	14	mechanical	mechanical	ADJ
dpc-2776	87	15	low	low	ADJ
dpc-2776	87	16	back	back	ADJ
dpc-2776	87	17	pain	pain	NOUN
dpc-2776	88	1	[	[	X
dpc-2776	88	2	9	9	NUM
dpc-2776	88	3	]	]	PUNCT
dpc-2776	88	4	.	.	PUNCT
dpc-2776	89	1	approximately	approximately	ADV
dpc-2776	89	2	16	16	NUM
dpc-2776	89	3	percent	percent	NOUN
dpc-2776	89	4	of	of	ADP
dpc-2776	89	5	the	the	DET
dpc-2776	89	6	patients	patient	NOUN
dpc-2776	89	7	receiving	receive	VERB
dpc-2776	89	8	systemic	systemic	ADJ
dpc-2776	89	9	isotretinoin	isotretinoin	PROPN
dpc-2776	89	10	therapy	therapy	NOUN
dpc-2776	89	11	develop	develop	VERB
dpc-2776	89	12	musculoskeletal	musculoskeletal	ADJ
dpc-2776	89	13	side	side	NOUN
dpc-2776	89	14	effects	effect	NOUN
dpc-2776	89	15	including	include	VERB
dpc-2776	89	16	myalgia	myalgia	NOUN
dpc-2776	89	17	,	,	PUNCT
dpc-2776	89	18	arthralgia	arthralgia	NOUN
dpc-2776	89	19	and	and	CCONJ
dpc-2776	89	20	low	low	ADJ
dpc-2776	89	21	back	back	ADJ
dpc-2776	89	22	pain	pain	NOUN
dpc-2776	89	23	.	.	PUNCT
dpc-2776	90	1	although	although	SCONJ
dpc-2776	90	2	rare	rare	ADJ
dpc-2776	90	3	,	,	PUNCT
dpc-2776	90	4	sacroiliitis	sacroiliitis	NOUN
dpc-2776	90	5	can	can	AUX
dpc-2776	90	6	also	also	ADV
dpc-2776	90	7	be	be	AUX
dpc-2776	90	8	observed	observe	VERB
dpc-2776	90	9	in	in	ADP
dpc-2776	90	10	patients	patient	NOUN
dpc-2776	90	11	receiving	receive	VERB
dpc-2776	90	12	systemic	systemic	ADJ
dpc-2776	90	13	isotretinoin	isotretinoin	PROPN
dpc-2776	90	14	therapy	therapy	NOUN
dpc-2776	90	15	,	,	PUNCT
dpc-2776	90	16	which	which	PRON
dpc-2776	90	17	can	can	AUX
dpc-2776	90	18	be	be	AUX
dpc-2776	90	19	classified	classify	VERB
dpc-2776	90	20	as	as	ADP
dpc-2776	90	21	a	a	DET
dpc-2776	90	22	cause	cause	NOUN
dpc-2776	90	23	of	of	ADP
dpc-2776	90	24	inflammatory	inflammatory	ADJ
dpc-2776	90	25	low	low	ADJ
dpc-2776	90	26	back	back	ADJ
dpc-2776	90	27	pain	pain	NOUN
dpc-2776	91	1	[	[	X
dpc-2776	91	2	10	10	NUM
dpc-2776	91	3	]	]	PUNCT
dpc-2776	91	4	.	.	PUNCT
dpc-2776	92	1	in	in	ADP
dpc-2776	92	2	this	this	DET
dpc-2776	92	3	study	study	NOUN
dpc-2776	92	4	,	,	PUNCT
dpc-2776	92	5	45	45	NUM
dpc-2776	92	6	patients	patient	NOUN
dpc-2776	92	7	(	(	PUNCT
dpc-2776	92	8	25	25	NUM
dpc-2776	92	9	%	%	NOUN
dpc-2776	92	10	)	)	PUNCT
dpc-2776	92	11	have	have	AUX
dpc-2776	92	12	reported	report	VERB
dpc-2776	92	13	low	low	ADJ
dpc-2776	92	14	back	back	ADJ
dpc-2776	92	15	pain	pain	NOUN
dpc-2776	92	16	;	;	PUNCT
dpc-2776	92	17	of	of	ADP
dpc-2776	92	18	which	which	PRON
dpc-2776	92	19	4	4	NUM
dpc-2776	92	20	(	(	PUNCT
dpc-2776	92	21	2.2	2.2	NUM
dpc-2776	92	22	%	%	NOUN
dpc-2776	92	23	)	)	PUNCT
dpc-2776	92	24	have	have	AUX
dpc-2776	92	25	been	be	AUX
dpc-2776	92	26	diagnosed	diagnose	VERB
dpc-2776	92	27	with	with	ADP
dpc-2776	92	28	inflammatory	inflammatory	ADJ
dpc-2776	92	29	low	low	ADJ
dpc-2776	92	30	back	back	ADJ
dpc-2776	92	31	pain	pain	NOUN
dpc-2776	92	32	and	and	CCONJ
dpc-2776	92	33	41	41	NUM
dpc-2776	92	34	(	(	PUNCT
dpc-2776	92	35	22.8	22.8	NUM
dpc-2776	92	36	%	%	NOUN
dpc-2776	92	37	)	)	PUNCT
dpc-2776	92	38	have	have	AUX
dpc-2776	92	39	been	be	AUX
dpc-2776	92	40	diagnosed	diagnose	VERB
dpc-2776	92	41	with	with	ADP
dpc-2776	92	42	mechanical	mechanical	ADJ
dpc-2776	92	43	low	low	ADJ
dpc-2776	92	44	back	back	ADJ
dpc-2776	92	45	pain	pain	NOUN
dpc-2776	92	46	by	by	ADP
dpc-2776	92	47	the	the	DET
dpc-2776	92	48	physical	physical	ADJ
dpc-2776	92	49	therapy	therapy	NOUN
dpc-2776	92	50	and	and	CCONJ
dpc-2776	92	51	rehabilitation	rehabilitation	NOUN
dpc-2776	92	52	specialist	specialist	NOUN
dpc-2776	92	53	.	.	PUNCT
dpc-2776	93	1	none	none	NOUN
dpc-2776	93	2	of	of	ADP
dpc-2776	93	3	the	the	DET
dpc-2776	93	4	patients	patient	NOUN
dpc-2776	93	5	were	be	AUX
dpc-2776	93	6	diagnosed	diagnose	VERB
dpc-2776	93	7	with	with	ADP
dpc-2776	93	8	sacroiliitis	sacroiliitis	PROPN
dpc-2776	93	9	.	.	PUNCT
dpc-2776	94	1	previous	previous	ADJ
dpc-2776	94	2	studies	study	NOUN
dpc-2776	94	3	on	on	ADP
dpc-2776	94	4	this	this	DET
dpc-2776	94	5	subject	subject	NOUN
dpc-2776	94	6	have	have	AUX
dpc-2776	94	7	reported	report	VERB
dpc-2776	94	8	a	a	DET
dpc-2776	94	9	prevalence	prevalence	NOUN
dpc-2776	94	10	of	of	ADP
dpc-2776	94	11	low	low	ADJ
dpc-2776	94	12	back	back	ADJ
dpc-2776	94	13	pain	pain	NOUN
dpc-2776	94	14	,	,	PUNCT
dpc-2776	94	15	among	among	ADP
dpc-2776	94	16	patients	patient	NOUN
dpc-2776	94	17	receiving	receive	VERB
dpc-2776	94	18	systemic	systemic	ADJ
dpc-2776	94	19	isotretinoin	isotretinoin	PROPN
dpc-2776	94	20	treatment	treatment	NOUN
dpc-2776	94	21	,	,	PUNCT
dpc-2776	94	22	of	of	ADP
dpc-2776	94	23	78.7	78.7	NUM
dpc-2776	94	24	%	%	NOUN
dpc-2776	94	25	,	,	PUNCT
dpc-2776	94	26	46.9	46.9	NUM
dpc-2776	94	27	%	%	NOUN
dpc-2776	94	28	,	,	PUNCT
dpc-2776	94	29	49.3	49.3	NUM
dpc-2776	94	30	%	%	NOUN
dpc-2776	94	31	and	and	CCONJ
dpc-2776	94	32	10.4	10.4	NUM
dpc-2776	94	33	%	%	NOUN
dpc-2776	94	34	[	[	X
dpc-2776	94	35	4,5,11,12	4,5,11,12	PROPN
dpc-2776	94	36	]	]	PUNCT
dpc-2776	94	37	.	.	PUNCT
dpc-2776	95	1	among	among	ADP
dpc-2776	95	2	the	the	DET
dpc-2776	95	3	patients	patient	NOUN
dpc-2776	95	4	with	with	ADP
dpc-2776	95	5	low	low	ADJ
dpc-2776	95	6	back	back	ADJ
dpc-2776	95	7	pain	pain	NOUN
dpc-2776	95	8	,	,	PUNCT
dpc-2776	95	9	60.3	60.3	NUM
dpc-2776	95	10	%	%	NOUN
dpc-2776	95	11	,	,	PUNCT
dpc-2776	95	12	54.7	54.7	NUM
dpc-2776	95	13	%	%	NOUN
dpc-2776	95	14	and	and	CCONJ
dpc-2776	95	15	44%1	44%1	NUM
dpc-2776	95	16	had	have	VERB
dpc-2776	95	17	inflammatory	inflammatory	ADJ
dpc-2776	95	18	 	 	SPACE
dpc-2776	95	19	low	low	ADJ
dpc-2776	95	20	back	back	ADJ
dpc-2776	95	21	pain	pain	NOUN
dpc-2776	96	1	[	[	X
dpc-2776	96	2	4,11,12	4,11,12	NUM
dpc-2776	96	3	]	]	PUNCT
dpc-2776	96	4	.	.	PUNCT
dpc-2776	97	1	we	we	PRON
dpc-2776	97	2	report	report	VERB
dpc-2776	97	3	a	a	DET
dpc-2776	97	4	lower	low	ADJ
dpc-2776	97	5	prevalence	prevalence	NOUN
dpc-2776	97	6	of	of	ADP
dpc-2776	97	7	low	low	ADJ
dpc-2776	97	8	back	back	ADJ
dpc-2776	97	9	pain	pain	NOUN
dpc-2776	97	10	and	and	CCONJ
dpc-2776	97	11	inflammatory	inflammatory	ADJ
dpc-2776	97	12	low	low	ADJ
dpc-2776	97	13	back	back	ADJ
dpc-2776	97	14	pain	pain	NOUN
dpc-2776	97	15	due	due	ADP
dpc-2776	97	16	to	to	ADP
dpc-2776	97	17	systemic	systemic	ADJ
dpc-2776	97	18	isotretinoin	isotretinoin	PROPN
dpc-2776	97	19	use	use	NOUN
dpc-2776	97	20	compared	compare	VERB
dpc-2776	97	21	to	to	ADP
dpc-2776	97	22	most	most	ADJ
dpc-2776	97	23	of	of	ADP
dpc-2776	97	24	the	the	DET
dpc-2776	97	25	studies	study	NOUN
dpc-2776	97	26	in	in	ADP
dpc-2776	97	27	the	the	DET
dpc-2776	97	28	literature	literature	NOUN
dpc-2776	97	29	.	.	PUNCT
dpc-2776	98	1	in	in	ADP
dpc-2776	98	2	our	our	PRON
dpc-2776	98	3	patient	patient	ADJ
dpc-2776	98	4	population	population	NOUN
dpc-2776	98	5	,	,	PUNCT
dpc-2776	98	6	the	the	DET
dpc-2776	98	7	prevalence	prevalence	NOUN
dpc-2776	98	8	of	of	ADP
dpc-2776	98	9	fatigue	fatigue	NOUN
dpc-2776	98	10	was	be	AUX
dpc-2776	98	11	4.4	4.4	NUM
dpc-2776	98	12	%	%	NOUN
dpc-2776	98	13	and	and	CCONJ
dpc-2776	98	14	of	of	ADP
dpc-2776	98	15	myalgia	myalgia	NOUN
dpc-2776	98	16	was	be	AUX
dpc-2776	98	17	2.8	2.8	NUM
dpc-2776	98	18	%	%	NOUN
dpc-2776	98	19	.	.	PUNCT
dpc-2776	99	1	in	in	ADP
dpc-2776	99	2	the	the	DET
dpc-2776	99	3	literature	literature	NOUN
dpc-2776	99	4	,	,	PUNCT
dpc-2776	99	5	fatigue	fatigue	NOUN
dpc-2776	99	6	has	have	AUX
dpc-2776	99	7	been	be	AUX
dpc-2776	99	8	reported	report	VERB
dpc-2776	99	9	to	to	PART
dpc-2776	99	10	have	have	VERB
dpc-2776	99	11	a	a	DET
dpc-2776	99	12	prevalence	prevalence	NOUN
dpc-2776	99	13	of	of	ADP
dpc-2776	99	14	54	54	NUM
dpc-2776	99	15	%	%	NOUN
dpc-2776	99	16	and	and	CCONJ
dpc-2776	99	17	of	of	ADP
dpc-2776	99	18	50.7	50.7	NUM
dpc-2776	99	19	%	%	NOUN
dpc-2776	100	1	[	[	X
dpc-2776	100	2	11,12	11,12	NOUN
dpc-2776	100	3	]	]	PUNCT
dpc-2776	100	4	;	;	PUNCT
dpc-2776	100	5	myalgia	myalgia	PROPN
dpc-2776	100	6	has	have	AUX
dpc-2776	100	7	been	be	AUX
dpc-2776	100	8	reported	report	VERB
dpc-2776	100	9	to	to	PART
dpc-2776	100	10	have	have	VERB
dpc-2776	100	11	a	a	DET
dpc-2776	100	12	prevalence	prevalence	NOUN
dpc-2776	100	13	of	of	ADP
dpc-2776	100	14	46.9	46.9	NUM
dpc-2776	100	15	%	%	NOUN
dpc-2776	100	16	and	and	CCONJ
dpc-2776	100	17	42.5	42.5	NUM
dpc-2776	100	18	%	%	NOUN
dpc-2776	101	1	[	[	X
dpc-2776	101	2	11,12	11,12	NUM
dpc-2776	101	3	]	]	PUNCT
dpc-2776	101	4	again	again	ADV
dpc-2776	101	5	,	,	PUNCT
dpc-2776	101	6	we	we	PRON
dpc-2776	101	7	report	report	VERB
dpc-2776	101	8	a	a	DET
dpc-2776	101	9	lower	low	ADJ
dpc-2776	101	10	prevalence	prevalence	NOUN
dpc-2776	101	11	of	of	ADP
dpc-2776	101	12	fatigue	fatigue	NOUN
dpc-2776	101	13	and	and	CCONJ
dpc-2776	101	14	myalgia	myalgia	NOUN
dpc-2776	101	15	due	due	ADP
dpc-2776	101	16	to	to	ADP
dpc-2776	101	17	systemic	systemic	ADJ
dpc-2776	101	18	isotretinoin	isotretinoin	PROPN
dpc-2776	101	19	therapy	therapy	NOUN
dpc-2776	101	20	compared	compare	VERB
dpc-2776	101	21	to	to	ADP
dpc-2776	101	22	the	the	DET
dpc-2776	101	23	literature	literature	NOUN
dpc-2776	101	24	.	.	PUNCT
dpc-2776	102	1	the	the	DET
dpc-2776	102	2	average	average	ADJ
dpc-2776	102	3	daily	daily	NOUN
dpc-2776	102	4	dose	dose	NOUN
dpc-2776	102	5	of	of	ADP
dpc-2776	102	6	systemic	systemic	ADJ
dpc-2776	102	7	isotretinoin	isotretinoin	PROPN
dpc-2776	102	8	prescribed	prescribe	VERB
dpc-2776	102	9	in	in	ADP
dpc-2776	102	10	our	our	PRON
dpc-2776	102	11	study	study	NOUN
dpc-2776	102	12	(	(	PUNCT
dpc-2776	102	13	0.582	0.582	NUM
dpc-2776	102	14	mg	mg	PROPN
dpc-2776	102	15	/	/	SYM
dpc-2776	102	16	kg	kg	PROPN
dpc-2776	102	17	/	/	SYM
dpc-2776	102	18	day	day	NOUN
dpc-2776	102	19	)	)	PUNCT
dpc-2776	102	20	is	be	AUX
dpc-2776	102	21	similar	similar	ADJ
dpc-2776	102	22	to	to	ADP
dpc-2776	102	23	the	the	DET
dpc-2776	102	24	table	table	NOUN
dpc-2776	102	25	3	3	NUM
dpc-2776	102	26	.	.	X
dpc-2776	102	27	relationship	relationship	NOUN
dpc-2776	102	28	of	of	ADP
dpc-2776	102	29	the	the	DET
dpc-2776	102	30	character	character	NOUN
dpc-2776	102	31	of	of	ADP
dpc-2776	102	32	low	low	ADJ
dpc-2776	102	33	back	back	ADJ
dpc-2776	102	34	pain	pain	NOUN
dpc-2776	102	35	to	to	ADP
dpc-2776	102	36	patient	patient	ADJ
dpc-2776	102	37	characteristics	characteristic	NOUN
dpc-2776	102	38	.	.	PUNCT
dpc-2776	103	1	character	character	NOUN
dpc-2776	103	2	of	of	ADP
dpc-2776	103	3	low	low	ADJ
dpc-2776	103	4	back	back	ADJ
dpc-2776	103	5	pain	pain	NOUN
dpc-2776	103	6	pinflammatory	pinflammatory	NOUN
dpc-2776	103	7	(	(	PUNCT
dpc-2776	103	8	n	n	NOUN
dpc-2776	103	9	=	=	SYM
dpc-2776	103	10	4	4	X
dpc-2776	103	11	)	)	PUNCT
dpc-2776	103	12	mechanical	mechanical	NOUN
dpc-2776	103	13	(	(	PUNCT
dpc-2776	103	14	n	n	NOUN
dpc-2776	103	15	=	=	SYM
dpc-2776	103	16	41	41	NUM
dpc-2776	103	17	)	)	PUNCT
dpc-2776	103	18	age	age	NOUN
dpc-2776	103	19	22.8	22.8	NUM
dpc-2776	103	20	±	±	NUM
dpc-2776	103	21	9.7	9.7	NUM
dpc-2776	103	22	19	19	NUM
dpc-2776	103	23	(	(	PUNCT
dpc-2776	103	24	16.3	16.3	NUM
dpc-2776	103	25	–	–	PUNCT
dpc-2776	103	26	33	33	NUM
dpc-2776	103	27	)	)	PUNCT
dpc-2776	103	28	19	19	NUM
dpc-2776	103	29	±	±	NUM
dpc-2776	103	30	3.4	3.4	NUM
dpc-2776	103	31	19	19	NUM
dpc-2776	103	32	(	(	PUNCT
dpc-2776	103	33	16	16	NUM
dpc-2776	103	34	–	–	SYM
dpc-2776	103	35	21	21	NUM
dpc-2776	103	36	)	)	PUNCT
dpc-2776	103	37	0.631a	0.631a	ADJ
dpc-2776	103	38	gender	gender	NOUN
dpc-2776	103	39	male	male	ADJ
dpc-2776	103	40	female	female	ADJ
dpc-2776	103	41	3	3	NUM
dpc-2776	103	42	(	(	PUNCT
dpc-2776	103	43	21.4	21.4	NUM
dpc-2776	103	44	)	)	PUNCT
dpc-2776	103	45	1	1	NUM
dpc-2776	103	46	(	(	PUNCT
dpc-2776	103	47	3.2	3.2	NUM
dpc-2776	103	48	)	)	PUNCT
dpc-2776	103	49	11	11	NUM
dpc-2776	103	50	(	(	PUNCT
dpc-2776	103	51	78.6	78.6	NUM
dpc-2776	103	52	)	)	PUNCT
dpc-2776	103	53	30	30	NUM
dpc-2776	103	54	(	(	PUNCT
dpc-2776	103	55	96.8	96.8	NUM
dpc-2776	103	56	)	)	PUNCT
dpc-2776	103	57	0.082	0.082	NUM
dpc-2776	103	58	b	b	PROPN
dpc-2776	103	59	isotretinoin	isotretinoin	PROPN
dpc-2776	103	60	dose	dose	PROPN
dpc-2776	103	61	(	(	PUNCT
dpc-2776	103	62	mg	mg	PROPN
dpc-2776	103	63	/	/	SYM
dpc-2776	103	64	kg	kg	PROPN
dpc-2776	103	65	/	/	SYM
dpc-2776	103	66	day	day	NOUN
dpc-2776	103	67	)	)	PUNCT
dpc-2776	103	68	0.593	0.593	NUM
dpc-2776	103	69	±	±	NUM
dpc-2776	103	70	0.1	0.1	NUM
dpc-2776	103	71	0.585	0.585	NUM
dpc-2776	103	72	(	(	PUNCT
dpc-2776	103	73	0.5	0.5	NUM
dpc-2776	103	74	–	–	PUNCT
dpc-2776	103	75	0.693	0.693	NUM
dpc-2776	103	76	)	)	PUNCT
dpc-2776	103	77	0.599	0.599	NUM
dpc-2776	103	78	±	±	NUM
dpc-2776	103	79	0.2	0.2	NUM
dpc-2776	103	80	0.6	0.6	NUM
dpc-2776	103	81	(	(	PUNCT
dpc-2776	103	82	0.5	0.5	NUM
dpc-2776	103	83	–	–	PUNCT
dpc-2776	103	84	0.695	0.695	NUM
dpc-2776	103	85	)	)	PUNCT
dpc-2776	103	86	0.967	0.967	NUM
dpc-2776	103	87	a	a	DET
dpc-2776	103	88	treatment	treatment	NOUN
dpc-2776	103	89	duration	duration	NOUN
dpc-2776	103	90	(	(	PUNCT
dpc-2776	103	91	weeks	week	NOUN
dpc-2776	103	92	)	)	PUNCT
dpc-2776	103	93	6.3	6.3	NUM
dpc-2776	103	94	±	±	NUM
dpc-2776	103	95	6.7	6.7	NUM
dpc-2776	103	96	4	4	NUM
dpc-2776	103	97	(	(	PUNCT
dpc-2776	103	98	1.75	1.75	NUM
dpc-2776	103	99	–	–	SYM
dpc-2776	103	100	13	13	NUM
dpc-2776	103	101	)	)	PUNCT
dpc-2776	103	102	9.2	9.2	NUM
dpc-2776	103	103	±	±	NUM
dpc-2776	103	104	6.7	6.7	NUM
dpc-2776	103	105	8	8	NUM
dpc-2776	103	106	(	(	PUNCT
dpc-2776	103	107	4	4	NUM
dpc-2776	103	108	–	–	SYM
dpc-2776	103	109	12	12	NUM
dpc-2776	103	110	)	)	PUNCT
dpc-2776	103	111	0.234	0.234	NUM
dpc-2776	103	112	a	a	DET
dpc-2776	103	113	isotretinoin	isotretinoin	PROPN
dpc-2776	103	114	naiveness	naiveness	NOUN
dpc-2776	103	115	naive	naive	ADJ
dpc-2776	103	116	not	not	PART
dpc-2776	103	117	naive	naive	ADJ
dpc-2776	103	118	3	3	NUM
dpc-2776	103	119	(	(	PUNCT
dpc-2776	103	120	7.9	7.9	NUM
dpc-2776	103	121	)	)	SYM
dpc-2776	103	122	1	1	NUM
dpc-2776	103	123	(	(	PUNCT
dpc-2776	103	124	14.3	14.3	NUM
dpc-2776	103	125	)	)	PUNCT
dpc-2776	103	126	35	35	NUM
dpc-2776	103	127	(	(	PUNCT
dpc-2776	103	128	92.1	92.1	NUM
dpc-2776	103	129	)	)	PUNCT
dpc-2776	103	130	6	6	NUM
dpc-2776	103	131	(	(	PUNCT
dpc-2776	103	132	85.7	85.7	NUM
dpc-2776	103	133	)	)	PUNCT
dpc-2776	103	134	0.505	0.505	NUM
dpc-2776	103	135	b	b	NOUN
dpc-2776	103	136	a	a	DET
dpc-2776	103	137	mann	mann	PROPN
dpc-2776	103	138	whitney	whitney	PROPN
dpc-2776	103	139	u	u	PROPN
dpc-2776	103	140	test	test	NOUN
dpc-2776	103	141	;	;	PUNCT
dpc-2776	103	142	b	b	X
dpc-2776	103	143	fisher	fisher	PROPN
dpc-2776	103	144	exact	exact	ADJ
dpc-2776	103	145	test	test	NOUN
dpc-2776	103	146	.	.	PUNCT
dpc-2776	104	1	original	original	ADJ
dpc-2776	104	2	article	article	NOUN
dpc-2776	104	3	|	|	ADV
dpc-2776	104	4	dermatol	dermatol	ADJ
dpc-2776	104	5	pract	pract	NOUN
dpc-2776	104	6	concept	concept	NOUN
dpc-2776	104	7	.	.	PUNCT
dpc-2776	105	1	2023;13(2):e2023121	2023;13(2):e2023121	NUM
dpc-2776	105	2	5	5	NUM
dpc-2776	105	3	references	reference	NOUN
dpc-2776	105	4	1	1	NUM
dpc-2776	105	5	.	.	PUNCT
dpc-2776	105	6	layton	layton	PROPN
dpc-2776	105	7	a.	a.	NOUN
dpc-2776	106	1	the	the	DET
dpc-2776	106	2	use	use	NOUN
dpc-2776	106	3	of	of	ADP
dpc-2776	106	4	isotretinoin	isotretinoin	PROPN
dpc-2776	106	5	in	in	ADP
dpc-2776	106	6	acne	acne	PROPN
dpc-2776	106	7	.	.	PUNCT
dpc-2776	107	1	dermatoendocrinol	dermatoendocrinol	NOUN
dpc-2776	107	2	.	.	PUNCT
dpc-2776	108	1	2009;1(3):162	2009;1(3):162	NUM
dpc-2776	108	2	-	-	SYM
dpc-2776	108	3	169	169	NUM
dpc-2776	108	4	.	.	PUNCT
dpc-2776	109	1	doi	doi	NOUN
dpc-2776	109	2	:	:	PUNCT
dpc-2776	109	3	10.4161	10.4161	NUM
dpc-2776	109	4	/	/	SYM
dpc-2776	109	5	derm.1.3.9364	derm.1.3.9364	NOUN
dpc-2776	109	6	.	.	PUNCT
dpc-2776	110	1	pmid	pmid	NOUN
dpc-2776	110	2	:	:	PUNCT
dpc-2776	110	3	20436884	20436884	NUM
dpc-2776	110	4	.	.	PUNCT
dpc-2776	111	1	pmcid	pmcid	ADJ
dpc-2776	111	2	:	:	PUNCT
dpc-2776	111	3	pmc2835909	pmc2835909	ADJ
dpc-2776	111	4	.	.	PUNCT
dpc-2776	112	1	2	2	X
dpc-2776	112	2	.	.	X
dpc-2776	112	3	leyden	leyden	PROPN
dpc-2776	112	4	jj	jj	PROPN
dpc-2776	112	5	,	,	PUNCT
dpc-2776	112	6	del	del	PROPN
dpc-2776	112	7	rosso	rosso	PROPN
dpc-2776	112	8	jq	jq	PROPN
dpc-2776	112	9	,	,	PUNCT
dpc-2776	112	10	baum	baum	PROPN
dpc-2776	112	11	ew	ew	PROPN
dpc-2776	112	12	.	.	PUNCT
dpc-2776	113	1	the	the	DET
dpc-2776	113	2	use	use	NOUN
dpc-2776	113	3	of	of	ADP
dpc-2776	113	4	isotretinoin	isotretinoin	PROPN
dpc-2776	113	5	in	in	ADP
dpc-2776	113	6	the	the	DET
dpc-2776	113	7	treatment	treatment	NOUN
dpc-2776	113	8	of	of	ADP
dpc-2776	113	9	acne	acne	NOUN
dpc-2776	113	10	vulgaris	vulgaris	NOUN
dpc-2776	113	11	:	:	PUNCT
dpc-2776	113	12	clinical	clinical	ADJ
dpc-2776	113	13	considerations	consideration	NOUN
dpc-2776	113	14	and	and	CCONJ
dpc-2776	113	15	future	future	ADJ
dpc-2776	113	16	directions	direction	NOUN
dpc-2776	113	17	.	.	PUNCT
dpc-2776	114	1	j	j	PROPN
dpc-2776	114	2	clin	clin	PROPN
dpc-2776	114	3	aesthet	aesthet	PROPN
dpc-2776	114	4	dermatol	dermatol	PROPN
dpc-2776	114	5	.	.	PUNCT
dpc-2776	115	1	2014;7(2):s3	2014;7(2):s3	NUM
dpc-2776	115	2	-	-	PUNCT
dpc-2776	115	3	s21	s21	NOUN
dpc-2776	115	4	.	.	PUNCT
dpc-2776	116	1	pmid	pmid	NOUN
dpc-2776	116	2	:	:	PUNCT
dpc-2776	116	3	24688620	24688620	NUM
dpc-2776	116	4	.	.	PUNCT
dpc-2776	117	1	pmcid	pmcid	ADJ
dpc-2776	117	2	:	:	PUNCT
dpc-2776	117	3	pmc3970835	pmc3970835	NOUN
dpc-2776	117	4	.	.	PUNCT
dpc-2776	118	1	3	3	X
dpc-2776	118	2	.	.	X
dpc-2776	118	3	kaplan	kaplan	PROPN
dpc-2776	118	4	g	g	PROPN
dpc-2776	118	5	,	,	PUNCT
dpc-2776	118	6	haettich	haettich	PROPN
dpc-2776	118	7	b.	b.	PROPN
dpc-2776	118	8	rheumatological	rheumatological	ADJ
dpc-2776	118	9	symptoms	symptom	NOUN
dpc-2776	118	10	due	due	ADJ
dpc-2776	118	11	to	to	ADP
dpc-2776	118	12	retinoids	retinoid	NOUN
dpc-2776	118	13	.	.	PUNCT
dpc-2776	119	1	baillieres	baillieres	PROPN
dpc-2776	119	2	clin	clin	PROPN
dpc-2776	119	3	rheumatol	rheumatol	NOUN
dpc-2776	119	4	.	.	PUNCT
dpc-2776	120	1	1991;5(1):77–97	1991;5(1):77–97	NUM
dpc-2776	120	2	.	.	PUNCT
dpc-2776	121	1	doi	doi	NOUN
dpc-2776	121	2	:	:	PUNCT
dpc-2776	121	3	10.1016	10.1016	NUM
dpc-2776	121	4	/	/	SYM
dpc-2776	121	5	s0950	s0950	PROPN
dpc-2776	121	6	-	-	PUNCT
dpc-2776	121	7	3579(05)80297	3579(05)80297	NUM
dpc-2776	121	8	-	-	PUNCT
dpc-2776	121	9	3	3	NUM
dpc-2776	121	10	.	.	PUNCT
dpc-2776	122	1	pmid	pmid	NOUN
dpc-2776	122	2	:	:	PUNCT
dpc-2776	122	3	2070429	2070429	NUM
dpc-2776	122	4	.	.	PUNCT
dpc-2776	123	1	4	4	X
dpc-2776	123	2	.	.	X
dpc-2776	123	3	acar	acar	VERB
dpc-2776	123	4	em	em	PRON
dpc-2776	123	5	,	,	PUNCT
dpc-2776	123	6	şaş	şaş	X
dpc-2776	123	7	s	s	PROPN
dpc-2776	123	8	,	,	PUNCT
dpc-2776	123	9	aybala	aybala	PROPN
dpc-2776	123	10	koçak	koçak	PROPN
dpc-2776	123	11	f.	f.	PROPN
dpc-2776	123	12	evaluation	evaluation	NOUN
dpc-2776	123	13	of	of	ADP
dpc-2776	123	14	musculoskeletal	musculoskeletal	ADJ
dpc-2776	123	15	adverse	adverse	ADJ
dpc-2776	123	16	effects	effect	NOUN
dpc-2776	123	17	in	in	ADP
dpc-2776	123	18	patients	patient	NOUN
dpc-2776	123	19	on	on	ADP
dpc-2776	123	20	systemic	systemic	ADJ
dpc-2776	123	21	isotretinoin	isotretinoin	PROPN
dpc-2776	123	22	treatment	treatment	NOUN
dpc-2776	123	23	:	:	PUNCT
dpc-2776	123	24	a	a	DET
dpc-2776	123	25	cross	cross	ADJ
dpc-2776	123	26	-	-	ADJ
dpc-2776	123	27	sectional	sectional	ADJ
dpc-2776	123	28	study	study	NOUN
dpc-2776	123	29	.	.	PUNCT
dpc-2776	124	1	arch	arch	ADJ
dpc-2776	124	2	rheumatol	rheumatol	NOUN
dpc-2776	124	3	.	.	PUNCT
dpc-2776	125	1	2022;37(2):223	2022;37(2):223	NUM
dpc-2776	125	2	-	-	SYM
dpc-2776	125	3	229	229	NUM
dpc-2776	125	4	.	.	PUNCT
dpc-2776	126	1	doi	doi	NOUN
dpc-2776	126	2	:	:	PUNCT
dpc-2776	126	3	10.46497	10.46497	NUM
dpc-2776	126	4	/	/	SYM
dpc-2776	126	5	archrheumatol.2022.8645	archrheumatol.2022.8645	PROPN
dpc-2776	126	6	.	.	PUNCT
dpc-2776	127	1	pmid	pmid	NOUN
dpc-2776	127	2	:	:	PUNCT
dpc-2776	127	3	36017204	36017204	NUM
dpc-2776	127	4	.	.	PUNCT
dpc-2776	128	1	pmcid	pmcid	NOUN
dpc-2776	128	2	:	:	PUNCT
dpc-2776	128	3	pmc9377170	pmc9377170	NOUN
dpc-2776	128	4	.	.	PUNCT
dpc-2776	129	1	5	5	X
dpc-2776	129	2	.	.	X
dpc-2776	129	3	civelek	civelek	PROPN
dpc-2776	129	4	u	u	PROPN
dpc-2776	129	5	,	,	PUNCT
dpc-2776	129	6	baykal	baykal	PROPN
dpc-2776	129	7	l	l	PROPN
dpc-2776	129	8	,	,	PUNCT
dpc-2776	129	9	aksu	aksu	PROPN
dpc-2776	129	10	arica	arica	PROPN
dpc-2776	130	1	d	d	PROPN
dpc-2776	130	2	,	,	PUNCT
dpc-2776	130	3	capkin	capkin	NOUN
dpc-2776	130	4	e	e	NOUN
dpc-2776	130	5	,	,	PUNCT
dpc-2776	130	6	yayli	yayli	PROPN
dpc-2776	130	7	s.	s.	PROPN
dpc-2776	130	8	isotretinoin	isotretinoin	PROPN
dpc-2776	130	9	-	-	PUNCT
dpc-2776	130	10	induced	induce	VERB
dpc-2776	130	11	inflammatory	inflammatory	ADJ
dpc-2776	130	12	back	back	ADJ
dpc-2776	130	13	pain	pain	NOUN
dpc-2776	130	14	and	and	CCONJ
dpc-2776	130	15	sacroiliitis	sacroiliitis	NOUN
dpc-2776	130	16	in	in	ADP
dpc-2776	130	17	patients	patient	NOUN
dpc-2776	130	18	with	with	ADP
dpc-2776	130	19	moderate	moderate	ADJ
dpc-2776	130	20	to	to	ADP
dpc-2776	130	21	severe	severe	ADJ
dpc-2776	130	22	acne	acne	NOUN
dpc-2776	130	23	vulgaris	vulgaris	NOUN
dpc-2776	130	24	.	.	PUNCT
dpc-2776	131	1	j	j	PROPN
dpc-2776	131	2	cosmet	cosmet	PROPN
dpc-2776	131	3	dermatol	dermatol	NOUN
dpc-2776	131	4	.	.	PUNCT
dpc-2776	132	1	2022;21(10):4846	2022;21(10):4846	NUM
dpc-2776	132	2	-	-	SYM
dpc-2776	132	3	4851	4851	NUM
dpc-2776	132	4	.	.	PUNCT
dpc-2776	133	1	doi	doi	NOUN
dpc-2776	133	2	:	:	PUNCT
dpc-2776	133	3	10.1111	10.1111	NUM
dpc-2776	133	4	/	/	SYM
dpc-2776	133	5	jocd.14807	jocd.14807	PROPN
dpc-2776	133	6	.	.	PUNCT
dpc-2776	134	1	pmid	pmid	NOUN
dpc-2776	134	2	:	:	PUNCT
dpc-2776	134	3	35092165	35092165	NUM
dpc-2776	134	4	.	.	PUNCT
dpc-2776	135	1	6	6	X
dpc-2776	135	2	.	.	X
dpc-2776	135	3	agarwal	agarwal	PROPN
dpc-2776	135	4	us	we	PRON
dpc-2776	135	5	,	,	PUNCT
dpc-2776	135	6	besarwal	besarwal	VERB
dpc-2776	135	7	rk	rk	PRON
dpc-2776	135	8	,	,	PUNCT
dpc-2776	135	9	bhola	bhola	PROPN
dpc-2776	135	10	k.	k.	PROPN
dpc-2776	136	1	oral	oral	PROPN
dpc-2776	136	2	isotretinoin	isotretinoin	PROPN
dpc-2776	136	3	in	in	ADP
dpc-2776	136	4	different	different	ADJ
dpc-2776	136	5	dose	dose	NOUN
dpc-2776	136	6	regimens	regimen	NOUN
dpc-2776	136	7	for	for	ADP
dpc-2776	136	8	acne	acne	NOUN
dpc-2776	136	9	vulgaris	vulgaris	NOUN
dpc-2776	136	10	:	:	PUNCT
dpc-2776	136	11	a	a	DET
dpc-2776	136	12	randomized	randomized	ADJ
dpc-2776	136	13	comparative	comparative	ADJ
dpc-2776	136	14	trial	trial	NOUN
dpc-2776	136	15	.	.	PUNCT
dpc-2776	137	1	indian	indian	PROPN
dpc-2776	137	2	j	j	PROPN
dpc-2776	137	3	dermatol	dermatol	PROPN
dpc-2776	137	4	venereol	venereol	ADJ
dpc-2776	137	5	leprol	leprol	NOUN
dpc-2776	137	6	.	.	PUNCT
dpc-2776	138	1	2011;77(6):688	2011;77(6):688	NUM
dpc-2776	138	2	-	-	PUNCT
dpc-2776	138	3	694	694	NUM
dpc-2776	138	4	.	.	PUNCT
dpc-2776	139	1	doi	doi	NOUN
dpc-2776	139	2	:	:	PUNCT
dpc-2776	139	3	10.4103/0378	10.4103/0378	NUM
dpc-2776	139	4	-	-	PUNCT
dpc-2776	139	5	6323.86482	6323.86482	NUM
dpc-2776	139	6	.	.	PUNCT
dpc-2776	140	1	pmid	pmid	NOUN
dpc-2776	140	2	:	:	PUNCT
dpc-2776	140	3	22016276	22016276	NUM
dpc-2776	140	4	.	.	PUNCT
dpc-2776	141	1	7	7	X
dpc-2776	141	2	.	.	X
dpc-2776	141	3	kapała	kapała	PROPN
dpc-2776	141	4	j	j	PROPN
dpc-2776	141	5	,	,	PUNCT
dpc-2776	141	6	lewandowska	lewandowska	PROPN
dpc-2776	141	7	j	j	PROPN
dpc-2776	141	8	,	,	PUNCT
dpc-2776	141	9	placek	placek	PROPN
dpc-2776	141	10	w	w	PROPN
dpc-2776	141	11	,	,	PUNCT
dpc-2776	141	12	owczarczyk	owczarczyk	ADJ
dpc-2776	141	13	-	-	PUNCT
dpc-2776	141	14	saczonek	saczonek	ADJ
dpc-2776	141	15	a.	a.	NOUN
dpc-2776	141	16	adverse	adverse	ADJ
dpc-2776	141	17	events	event	NOUN
dpc-2776	141	18	in	in	ADP
dpc-2776	141	19	isotretinoin	isotretinoin	PROPN
dpc-2776	141	20	therapy	therapy	NOUN
dpc-2776	141	21	:	:	PUNCT
dpc-2776	141	22	a	a	DET
dpc-2776	141	23	single	single	ADJ
dpc-2776	141	24	-	-	PUNCT
dpc-2776	141	25	arm	arm	NOUN
dpc-2776	141	26	meta	meta	ADJ
dpc-2776	141	27	-	-	PUNCT
dpc-2776	141	28	analysis	analysis	NOUN
dpc-2776	141	29	.	.	PUNCT
dpc-2776	142	1	int	int	PROPN
dpc-2776	143	1	j	j	PROPN
dpc-2776	143	2	environ	environ	PROPN
dpc-2776	143	3	res	re	VERB
dpc-2776	143	4	public	public	ADJ
dpc-2776	143	5	health	health	NOUN
dpc-2776	143	6	.	.	PUNCT
dpc-2776	144	1	2022;19(11):6463	2022;19(11):6463	X
dpc-2776	144	2	.	.	X
dpc-2776	144	3	doi	doi	NOUN
dpc-2776	144	4	:	:	PUNCT
dpc-2776	144	5	10.3390	10.3390	NUM
dpc-2776	144	6	/	/	SYM
dpc-2776	144	7	ijerph19116463	ijerph19116463	PROPN
dpc-2776	144	8	.	.	PUNCT
dpc-2776	145	1	pmid	pmid	NOUN
dpc-2776	145	2	:	:	PUNCT
dpc-2776	145	3	35682048	35682048	NUM
dpc-2776	145	4	.	.	PUNCT
dpc-2776	146	1	pmcid	pmcid	NOUN
dpc-2776	146	2	:	:	PUNCT
dpc-2776	146	3	pmc9180136	pmc9180136	ADJ
dpc-2776	146	4	.	.	PUNCT
dpc-2776	147	1	8	8	X
dpc-2776	147	2	.	.	X
dpc-2776	147	3	karaosmanoğlu	karaosmanoğlu	PROPN
dpc-2776	147	4	n	n	PROPN
dpc-2776	147	5	,	,	PUNCT
dpc-2776	147	6	mülkoğlu	mülkoğlu	ADJ
dpc-2776	147	7	c.	c.	NOUN
dpc-2776	147	8	analysis	analysis	NOUN
dpc-2776	147	9	of	of	ADP
dpc-2776	147	10	musculoskeletal	musculoskeletal	ADJ
dpc-2776	147	11	side	side	NOUN
dpc-2776	147	12	effects	effect	NOUN
dpc-2776	147	13	of	of	ADP
dpc-2776	147	14	oral	oral	ADJ
dpc-2776	147	15	isotretinoin	isotretinoin	PROPN
dpc-2776	147	16	treatment	treatment	NOUN
dpc-2776	147	17	:	:	PUNCT
dpc-2776	147	18	a	a	DET
dpc-2776	147	19	cross	cross	ADJ
dpc-2776	147	20	-	-	ADJ
dpc-2776	147	21	sectional	sectional	ADJ
dpc-2776	147	22	study	study	NOUN
dpc-2776	147	23	.	.	PUNCT
dpc-2776	148	1	bmc	bmc	PROPN
dpc-2776	148	2	musculoskelet	musculoskelet	NOUN
dpc-2776	148	3	disord	disord	NOUN
dpc-2776	148	4	.	.	PUNCT
dpc-2776	149	1	2020;21(1):631	2020;21(1):631	NOUN
dpc-2776	149	2	.	.	PUNCT
dpc-2776	150	1	doi	doi	NOUN
dpc-2776	150	2	:	:	PUNCT
dpc-2776	150	3	10.1186	10.1186	NUM
dpc-2776	150	4	/	/	SYM
dpc-2776	150	5	s12891	s12891	NOUN
dpc-2776	150	6	-	-	PUNCT
dpc-2776	150	7	020	020	NUM
dpc-2776	150	8	-	-	PUNCT
dpc-2776	150	9	03656	03656	NUM
dpc-2776	150	10	-	-	PUNCT
dpc-2776	150	11	w.	w.	NOUN
dpc-2776	150	12	pmid	pmid	PROPN
dpc-2776	150	13	:	:	PUNCT
dpc-2776	150	14	32977793	32977793	NUM
dpc-2776	150	15	.	.	PUNCT
dpc-2776	151	1	pmcid	pmcid	ADJ
dpc-2776	151	2	:	:	PUNCT
dpc-2776	151	3	pmc7519514	pmc7519514	NOUN
dpc-2776	151	4	.	.	PUNCT
dpc-2776	152	1	9	9	X
dpc-2776	152	2	.	.	X
dpc-2776	152	3	ledford	ledford	PROPN
dpc-2776	152	4	c.	c.	PROPN
dpc-2776	152	5	spine	spine	PROPN
dpc-2776	152	6	conditions	condition	NOUN
dpc-2776	152	7	:	:	PUNCT
dpc-2776	152	8	mechanical	mechanical	ADJ
dpc-2776	152	9	and	and	CCONJ
dpc-2776	152	10	inflammatory	inflammatory	ADJ
dpc-2776	152	11	low	low	ADJ
dpc-2776	152	12	back	back	ADJ
dpc-2776	152	13	pain	pain	NOUN
dpc-2776	152	14	.	.	PUNCT
dpc-2776	153	1	fp	fp	DET
dpc-2776	153	2	essent	essent	NOUN
dpc-2776	153	3	.	.	PUNCT
dpc-2776	154	1	2017;461:15	2017;461:15	NUM
dpc-2776	154	2	-	-	SYM
dpc-2776	154	3	20	20	NUM
dpc-2776	154	4	.	.	PUNCT
dpc-2776	155	1	pmid	pmid	NOUN
dpc-2776	155	2	:	:	PUNCT
dpc-2776	155	3	29019640	29019640	NUM
dpc-2776	155	4	.	.	PUNCT
dpc-2776	156	1	10	10	NUM
dpc-2776	156	2	.	.	PUNCT
dpc-2776	156	3	aydog	aydog	PROPN
dpc-2776	156	4	e	e	PROPN
dpc-2776	156	5	,	,	PUNCT
dpc-2776	156	6	ozturk	ozturk	NOUN
dpc-2776	156	7	g	g	NOUN
dpc-2776	156	8	,	,	PUNCT
dpc-2776	156	9	comert	comert	VERB
dpc-2776	156	10	a	a	PRON
dpc-2776	156	11	,	,	PUNCT
dpc-2776	156	12	tasdelen	tasdelen	ADJ
dpc-2776	156	13	n	n	CCONJ
dpc-2776	156	14	,	,	PUNCT
dpc-2776	156	15	akin	akin	ADJ
dpc-2776	156	16	o	o	NOUN
dpc-2776	156	17	,	,	PUNCT
dpc-2776	156	18	kulcu	kulcu	PROPN
dpc-2776	156	19	dg	dg	PROPN
dpc-2776	156	20	.	.	PUNCT
dpc-2776	157	1	sacroiliitis	sacroiliitis	PROPN
dpc-2776	157	2	during	during	ADP
dpc-2776	157	3	isotretinoin	isotretinoin	PROPN
dpc-2776	157	4	treatment	treatment	PROPN
dpc-2776	157	5	:	:	PUNCT
dpc-2776	157	6	causal	causal	ADJ
dpc-2776	157	7	association	association	NOUN
dpc-2776	157	8	or	or	CCONJ
dpc-2776	157	9	coincidence	coincidence	NOUN
dpc-2776	157	10	?	?	PUNCT
dpc-2776	158	1	north	north	PROPN
dpc-2776	158	2	clin	clin	PROPN
dpc-2776	158	3	istanb	istanb	PROPN
dpc-2776	158	4	.	.	PUNCT
dpc-2776	159	1	2018;6(1):75	2018;6(1):75	NUM
dpc-2776	159	2	-	-	SYM
dpc-2776	159	3	80	80	NUM
dpc-2776	159	4	.	.	PUNCT
dpc-2776	159	5	doi	doi	NOUN
dpc-2776	159	6	:	:	PUNCT
dpc-2776	159	7	10.14744	10.14744	NUM
dpc-2776	159	8	/	/	SYM
dpc-2776	159	9	nci.2018.93798	nci.2018.93798	NOUN
dpc-2776	159	10	.	.	PUNCT
dpc-2776	160	1	pmid	pmid	NOUN
dpc-2776	160	2	:	:	PUNCT
dpc-2776	160	3	31180372	31180372	NUM
dpc-2776	160	4	.	.	PUNCT
dpc-2776	161	1	pmcid	pmcid	NOUN
dpc-2776	161	2	:	:	PUNCT
dpc-2776	161	3	pmc6526982	pmc6526982	VERB
dpc-2776	161	4	.	.	PUNCT
dpc-2776	162	1	11	11	NUM
dpc-2776	162	2	.	.	X
dpc-2776	163	1	taheri	taheri	NOUN
dpc-2776	163	2	a	a	PROPN
dpc-2776	163	3	,	,	PUNCT
dpc-2776	163	4	sabouhi	sabouhi	VERB
dpc-2776	163	5	s	s	PART
dpc-2776	163	6	,	,	PUNCT
dpc-2776	163	7	farazmand	farazmand	NOUN
dpc-2776	163	8	f.	f.	PROPN
dpc-2776	163	9	incidence	incidence	NOUN
dpc-2776	163	10	of	of	ADP
dpc-2776	163	11	low	low	ADJ
dpc-2776	163	12	back	back	ADJ
dpc-2776	163	13	pain	pain	NOUN
dpc-2776	163	14	and	and	CCONJ
dpc-2776	163	15	sacroiliitis	sacroiliitis	NOUN
dpc-2776	163	16	in	in	ADP
dpc-2776	163	17	military	military	ADJ
dpc-2776	163	18	families	family	NOUN
dpc-2776	163	19	with	with	ADP
dpc-2776	163	20	acne	acne	NOUN
dpc-2776	163	21	vulgaris	vulgaris	NOUN
dpc-2776	163	22	under	under	ADP
dpc-2776	163	23	isotretinoin	isotretinoin	PROPN
dpc-2776	163	24	therapy	therapy	NOUN
dpc-2776	163	25	.	.	PUNCT
dpc-2776	163	26	  	  	SPACE
dpc-2776	164	1	am	be	AUX
dpc-2776	164	2	j	j	PROPN
dpc-2776	164	3	clin	clin	PROPN
dpc-2776	164	4	exp	exp	NOUN
dpc-2776	164	5	immunol	immunol	NOUN
dpc-2776	164	6	.	.	PUNCT
dpc-2776	165	1	2020;9(2):6	2020;9(2):6	PROPN
dpc-2776	165	2	-	-	PUNCT
dpc-2776	165	3	9	9	NUM
dpc-2776	165	4	.	.	PUNCT
dpc-2776	166	1	pmid	pmid	NOUN
dpc-2776	166	2	:	:	PUNCT
dpc-2776	166	3	32419981	32419981	NUM
dpc-2776	166	4	.	.	PUNCT
dpc-2776	167	1	pmcid	pmcid	NOUN
dpc-2776	167	2	:	:	PUNCT
dpc-2776	167	3	pmc7218680	pmc7218680	PROPN
dpc-2776	167	4	.	.	PUNCT
dpc-2776	168	1	12	12	NUM
dpc-2776	168	2	.	.	PUNCT
dpc-2776	169	1	baykal	baykal	PROPN
dpc-2776	169	2	selçuk	selçuk	PROPN
dpc-2776	169	3	l	l	PROPN
dpc-2776	169	4	,	,	PUNCT
dpc-2776	169	5	aksu	aksu	PROPN
dpc-2776	169	6	arıca	arıca	PROPN
dpc-2776	169	7	d	d	PROPN
dpc-2776	169	8	,	,	PUNCT
dpc-2776	169	9	baykal	baykal	PROPN
dpc-2776	169	10	şahin	şahin	PROPN
dpc-2776	169	11	h	h	PROPN
dpc-2776	169	12	,	,	PUNCT
dpc-2776	169	13	yaylı	yaylı	NOUN
dpc-2776	169	14	,	,	PUNCT
dpc-2776	169	15	bahadır	bahadır	PROPN
dpc-2776	169	16	 	 	SPACE
dpc-2776	169	17	s.	s.	PROPN
dpc-2776	169	18	the	the	DET
dpc-2776	169	19	prevalence	prevalence	NOUN
dpc-2776	169	20	of	of	ADP
dpc-2776	169	21	sacroiliitis	sacroiliitis	NOUN
dpc-2776	169	22	in	in	ADP
dpc-2776	169	23	patients	patient	NOUN
dpc-2776	169	24	with	with	ADP
dpc-2776	169	25	acne	acne	NOUN
dpc-2776	169	26	vulgaris	vulgaris	NOUN
dpc-2776	169	27	using	use	VERB
dpc-2776	169	28	isotretinoin	isotretinoin	PROPN
dpc-2776	169	29	..	..	PUNCT
dpc-2776	169	30	cutan	cutan	PROPN
dpc-2776	169	31	ocul	ocul	NOUN
dpc-2776	169	32	toxicol	toxicol	NOUN
dpc-2776	169	33	.	.	PUNCT
dpc-2776	170	1	2017;36(2):176	2017;36(2):176	NOUN
dpc-2776	170	2	-	-	SYM
dpc-2776	170	3	179	179	NUM
dpc-2776	170	4	.	.	PUNCT
dpc-2776	171	1	doi	doi	NOUN
dpc-2776	171	2	:	:	PUNCT
dpc-2776	171	3	10.1080/15569527.2016.1237521	10.1080/15569527.2016.1237521	NUM
dpc-2776	171	4	.	.	PUNCT
dpc-2776	172	1	pmid	pmid	NOUN
dpc-2776	172	2	:	:	PUNCT
dpc-2776	172	3	27764978	27764978	NUM
dpc-2776	172	4	.	.	PUNCT
dpc-2776	173	1	13	13	NUM
dpc-2776	173	2	.	.	PUNCT
dpc-2776	173	3	bauer	bauer	PROPN
dpc-2776	173	4	l	l	PROPN
dpc-2776	173	5	,	,	PUNCT
dpc-2776	173	6	ornelas	ornelas	PROPN
dpc-2776	173	7	j	j	PROPN
dpc-2776	173	8	,	,	PUNCT
dpc-2776	173	9	elston	elston	PROPN
dpc-2776	173	10	d	d	PROPN
dpc-2776	173	11	,	,	PUNCT
dpc-2776	173	12	alikhan	alikhan	PROPN
dpc-2776	173	13	  	  	SPACE
dpc-2776	173	14	a.	a.	NOUN
dpc-2776	173	15	  	  	SPACE
dpc-2776	173	16	isotretinoin	isotretinoin	PROPN
dpc-2776	173	17	:	:	PUNCT
dpc-2776	173	18	controversies	controversy	NOUN
dpc-2776	173	19	,	,	PUNCT
dpc-2776	173	20	facts	fact	NOUN
dpc-2776	173	21	,	,	PUNCT
dpc-2776	173	22	and	and	CCONJ
dpc-2776	173	23	recommendations	recommendation	NOUN
dpc-2776	173	24	.	.	PUNCT
dpc-2776	174	1	expert	expert	NOUN
dpc-2776	174	2	rev	rev	PROPN
dpc-2776	174	3	clin	clin	PROPN
dpc-2776	174	4	pharmacol	pharmacol	PROPN
dpc-2776	174	5	.	.	PUNCT
dpc-2776	175	1	2016;9(11):1435	2016;9(11):1435	NUM
dpc-2776	175	2	-	-	PUNCT
dpc-2776	175	3	1442	1442	NUM
dpc-2776	175	4	.	.	PUNCT
dpc-2776	176	1	doi	doi	NOUN
dpc-2776	176	2	:	:	PUNCT
dpc-2776	176	3	10.1080/17512433.2016.1213629	10.1080/17512433.2016.1213629	NUM
dpc-2776	176	4	.	.	PUNCT
dpc-2776	177	1	pmid	pmid	NOUN
dpc-2776	177	2	:	:	PUNCT
dpc-2776	177	3	27414637	27414637	NUM
dpc-2776	177	4	.	.	PUNCT